x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Ohio | 1-434 | 31-0411980 | ||
(State of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
One Procter & Gamble Plaza, Cincinnati, Ohio | 45202 | |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer | þ | Accelerated filer | ¨ | ||||
Non-accelerated filer | ¨ | (Do not check if smaller reporting company) | |||||
Smaller reporting company | ¨ | ||||||
Emerging growth company | ¨ |
Item 1. | Financial Statements |
Three Months Ended March 31 | Nine Months Ended March 31 | ||||||||||||||
Amounts in millions except per share amounts | 2018 | 2017 | 2018 | 2017 | |||||||||||
NET SALES | $ | $ | $ | $ | |||||||||||
Cost of products sold | |||||||||||||||
Selling, general and administrative expense | |||||||||||||||
OPERATING INCOME | |||||||||||||||
Interest expense | |||||||||||||||
Interest income | |||||||||||||||
Other non-operating income/(expense), net | ( | ) | |||||||||||||
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES | |||||||||||||||
Income taxes on continuing operations | |||||||||||||||
NET EARNINGS FROM CONTINUING OPERATIONS | |||||||||||||||
NET EARNINGS FROM DISCONTINUED OPERATIONS | |||||||||||||||
NET EARNINGS | |||||||||||||||
Less: Net earnings attributable to noncontrolling interests | |||||||||||||||
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ | $ | $ | $ | |||||||||||
BASIC NET EARNINGS PER COMMON SHARE (1) | |||||||||||||||
Earnings from continuing operations | $ | $ | $ | $ | |||||||||||
Earnings from discontinued operations | |||||||||||||||
BASIC NET EARNINGS PER COMMON SHARE | |||||||||||||||
DILUTED NET EARNINGS PER COMMON SHARE (1) | |||||||||||||||
Earnings from continuing operations | $ | $ | $ | $ | |||||||||||
Earnings from discontinued operations | |||||||||||||||
DILUTED NET EARNINGS PER COMMON SHARE | |||||||||||||||
DIVIDENDS PER COMMON SHARE | $ | $ | $ | $ | |||||||||||
Diluted Weighted Average Common Shares Outstanding |
(1) |
Three Months Ended March 31 | Nine Months Ended March 31 | ||||||||||||||
Amounts in millions | 2018 | 2017 | 2018 | 2017 | |||||||||||
NET EARNINGS | $ | $ | $ | $ | |||||||||||
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX | |||||||||||||||
Financial statement translation | ( | ) | |||||||||||||
Unrealized gains/(losses) on hedges | ( | ) | ( | ) | ( | ) | |||||||||
Unrealized gains/(losses) on investment securities | ( | ) | ( | ) | ( | ) | |||||||||
Unrealized gains/(losses) on defined benefit retirement plans | ( | ) | |||||||||||||
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX | ( | ) | |||||||||||||
TOTAL COMPREHENSIVE INCOME | |||||||||||||||
Less: Total comprehensive income attributable to noncontrolling interests | |||||||||||||||
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE | $ | $ | $ | $ |
Amounts in millions | March 31, 2018 | June 30, 2017 | ||||||||||
Assets | ||||||||||||
CURRENT ASSETS | ||||||||||||
Cash and cash equivalents | $ | $ | ||||||||||
Available-for-sale investment securities | ||||||||||||
Accounts receivable | ||||||||||||
INVENTORIES | ||||||||||||
Materials and supplies | ||||||||||||
Work in process | ||||||||||||
Finished goods | ||||||||||||
Total inventories | ||||||||||||
Prepaid expenses and other current assets | ||||||||||||
TOTAL CURRENT ASSETS | ||||||||||||
PROPERTY, PLANT AND EQUIPMENT, NET | ||||||||||||
GOODWILL | ||||||||||||
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET | ||||||||||||
OTHER NONCURRENT ASSETS | ||||||||||||
TOTAL ASSETS | $ | $ | ||||||||||
Liabilities and Shareholders' Equity | ||||||||||||
CURRENT LIABILITIES | ||||||||||||
Accounts payable | $ | $ | ||||||||||
Accrued and other liabilities | ||||||||||||
Debt due within one year | ||||||||||||
TOTAL CURRENT LIABILITIES | ||||||||||||
LONG-TERM DEBT | ||||||||||||
DEFERRED INCOME TAXES | ||||||||||||
OTHER NONCURRENT LIABILITIES | ||||||||||||
TOTAL LIABILITIES | ||||||||||||
SHAREHOLDERS’ EQUITY | ||||||||||||
Preferred stock | ||||||||||||
Common stock – shares issued – | March 2018 | |||||||||||
June 2017 | ||||||||||||
Additional paid-in capital | ||||||||||||
Reserve for ESOP debt retirement | ( | ) | ( | ) | ||||||||
Accumulated other comprehensive income/(loss) | ( | ) | ( | ) | ||||||||
Treasury stock | ( | ) | ( | ) | ||||||||
Retained earnings | ||||||||||||
Noncontrolling interest | ||||||||||||
TOTAL SHAREHOLDERS’ EQUITY | ||||||||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | $ |
Nine Months Ended March 31 | ||||||||
Amounts in millions | 2018 | 2017 | ||||||
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | $ | $ | ||||||
OPERATING ACTIVITIES | ||||||||
Net earnings | ||||||||
Depreciation and amortization | ||||||||
Loss on early extinguishment of debt | ||||||||
Share-based compensation expense | ||||||||
Deferred income taxes | ( | ) | ( | ) | ||||
Gain on sale of assets | ( | ) | ( | ) | ||||
Changes in: | ||||||||
Accounts receivable | ( | ) | ( | ) | ||||
Inventories | ( | ) | ( | ) | ||||
Accounts payable, accrued and other liabilities | ( | ) | ||||||
Other operating assets and liabilities | ||||||||
Other | ||||||||
TOTAL OPERATING ACTIVITIES | ||||||||
INVESTING ACTIVITIES | ||||||||
Capital expenditures | ( | ) | ( | ) | ||||
Proceeds from asset sales | ||||||||
Acquisitions, net of cash acquired | ( | ) | ( | ) | ||||
Purchases of short-term investments | ( | ) | ( | ) | ||||
Proceeds from sales and maturities of short-term investments | ||||||||
Pre-divestiture addition of restricted cash related to the Beauty Brands divestiture | ( | ) | ||||||
Cash transferred at closing related to the Beauty Brands divestiture | ( | ) | ||||||
Release of restricted cash upon closing of the Beauty Brands divestiture | ||||||||
Change in other investments | ||||||||
TOTAL INVESTING ACTIVITIES | ( | ) | ( | ) | ||||
FINANCING ACTIVITIES | ||||||||
Dividends to shareholders | ( | ) | ( | ) | ||||
Change in short-term debt | ( | ) | ||||||
Additions to long-term debt | ||||||||
Reductions of long-term debt | ( | ) | ( | ) | (1) | |||
Treasury stock purchases | ( | ) | ( | ) | ||||
Impact of stock options and other | ||||||||
TOTAL FINANCING ACTIVITIES | ( | ) | ( | ) | ||||
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | ( | ) | ||||||
CHANGE IN CASH AND CASH EQUIVALENTS | ( | ) | ( | ) | ||||
CASH AND CASH EQUIVALENTS, END OF PERIOD | $ | $ |
(1) |
Three Months Ended March 31 | Nine Months Ended March 31 | ||||||||||||||||||||||||
Net Sales | Earnings/(Loss) from Continuing Operations Before Income Taxes | Net Earnings/(Loss) from Continuing Operations | Net Sales | Earnings/(Loss) from Continuing Operations Before Income Taxes | Net Earnings/(Loss) from Continuing Operations | ||||||||||||||||||||
Beauty | 2018 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
2017 | |||||||||||||||||||||||||
Grooming | 2018 | ||||||||||||||||||||||||
2017 | |||||||||||||||||||||||||
Health Care | 2018 | ||||||||||||||||||||||||
2017 | |||||||||||||||||||||||||
Fabric & Home Care | 2018 | ||||||||||||||||||||||||
2017 | |||||||||||||||||||||||||
Baby, Feminine & Family Care | 2018 | ||||||||||||||||||||||||
2017 | |||||||||||||||||||||||||
Corporate | 2018 | ( | ) | ( | ) | ||||||||||||||||||||
2017 | ( | ) | |||||||||||||||||||||||
Total Company | 2018 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
2017 |
Beauty | Grooming | Health Care | Fabric & Home Care | Baby, Feminine & Family Care | Total Company | ||||||||||||||||||
Goodwill at June 30, 2017 | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Acquisitions and divestitures | |||||||||||||||||||||||
Translation and other | |||||||||||||||||||||||
Goodwill at March 31, 2018 | $ | $ | $ | $ | $ | $ |
Gross Carrying Amount | Accumulated Amortization | ||||||
Intangible assets with determinable lives | $ | $ | ( | ) | |||
Intangible assets with indefinite lives | |||||||
Total identifiable intangible assets | $ | $ | ( | ) |
Approximate Percent Change in Estimated Fair Value | |||||
+50 bps Discount Rate | -50 bps Long-term Growth | ||||
Shave Care goodwill reporting unit | ( | )% | ( | )% | |
Gillette indefinite-lived intangible asset | ( | )% | ( | )% |
Three Months Ended March 31, 2018 | Three Months Ended March 31, 2017 | ||||||||||||
CONSOLIDATED AMOUNTS | Total | Continuing Operations | Discontinued Operations | Total | |||||||||
Net earnings | $ | $ | $ | $ | |||||||||
Net earnings attributable to noncontrolling interests | ( | ) | ( | ) | ( | ) | |||||||
Net earnings attributable to P&G (Diluted) | |||||||||||||
Preferred dividends, net of tax benefit | ( | ) | ( | ) | ( | ) | |||||||
Net earnings attributable to P&G available to common shareholders (Basic) | $ | $ | $ | $ | |||||||||
SHARES IN MILLIONS | |||||||||||||
Basic weighted average common shares outstanding | |||||||||||||
Effect of dilutive securities | |||||||||||||
Conversion of preferred shares (1) | |||||||||||||
Exercise of stock options and other unvested equity awards (2) | |||||||||||||
Diluted weighted average common shares outstanding | |||||||||||||
PER SHARE AMOUNTS (3) | |||||||||||||
Basic net earnings per common share | $ | $ | $ | $ | |||||||||
Diluted net earnings per common share | $ | $ | $ | $ | |||||||||
Nine Months Ended March 31, 2018 | Nine Months Ended March 31, 2017 | ||||||||||||
CONSOLIDATED AMOUNTS | Total | Continuing Operations | Discontinued Operations | Total | |||||||||
Net earnings | $ | $ | $ | $ | |||||||||
Net earnings attributable to noncontrolling interests | ( | ) | ( | ) | ( | ) | |||||||
Net earnings attributable to P&G (Diluted) | |||||||||||||
Preferred dividends, net of tax benefit | ( | ) | ( | ) | ( | ) | |||||||
Net earnings attributable to P&G available to common shareholders (Basic) | $ | $ | $ | $ | |||||||||
SHARES IN MILLIONS | |||||||||||||
Basic weighted average common shares outstanding | |||||||||||||
Effect of dilutive securities | |||||||||||||
Conversion of preferred shares (1) | |||||||||||||
Exercise of stock options and other unvested equity awards (2) | |||||||||||||
Diluted weighted average common shares outstanding | |||||||||||||
PER SHARE AMOUNTS (3) | |||||||||||||
Basic net earnings per common share | $ | $ | $ | $ | |||||||||
Diluted net earnings per common share | $ | $ | $ | $ |
(1) |
(2) |
(3) |
Three Months Ended March 31 | Nine Months Ended March 31 | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Share-based compensation expense | $ | $ | $ | $ | |||||||||||
Net periodic benefit cost for pension benefits (1) | |||||||||||||||
Net periodic benefit cost/(credit) for other retiree benefits (1) | ( | ) | ( | ) | ( | ) |
(1) |
Fair Value Asset | |||||||
March 31, 2018 | June 30, 2017 | ||||||
Investments | |||||||
U.S. government securities | $ | $ | |||||
Corporate bond securities | |||||||
Other investments | |||||||
Total | $ | $ |
Notional Amount | Derivative Fair Value Asset/(Liability) | ||||||||||||||
March 31, 2018 | June 30, 2017 | March 31, 2018 | June 30, 2017 | ||||||||||||
Derivatives in Fair Value Hedging Relationships | |||||||||||||||
Interest rate contracts (1) | $ | $ | $ | $ | |||||||||||
Derivatives in Net Investment Hedging Relationships | |||||||||||||||
Foreign exchange contracts | $ | $ | $ | ( | ) | $ | ( | ) | |||||||
Derivatives Not Designated as Hedging Instruments | |||||||||||||||
Foreign currency contracts | $ | $ | $ | ( | ) | $ |
(1) |
Amount of Gain/(Loss) Recognized in AOCI on Derivatives | |||||||
March 31, 2018 | June 30, 2017 | ||||||
Derivatives in Net Investment Hedging Relationships | |||||||
Foreign exchange contracts | $ | ( | ) | $ | ( | ) |
Amount of Gain/(Loss) Reclassified from AOCI into Earnings | |||||||||||||||
Three Months Ended March 31 | Nine Months Ended March 31 | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Derivatives in Cash Flow Hedging Relationships (1) | |||||||||||||||
Foreign currency contracts | $ | $ | ( | ) | $ | $ | |||||||||
Amount of Gain/(Loss) Recognized in Earnings | |||||||||||||||
Three Months Ended March 31 | Nine Months Ended March 31 | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Derivatives in Fair Value Hedging Relationships (2) | |||||||||||||||
Interest rate contracts | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||
Debt | |||||||||||||||
Total | $ | $ | $ | $ | |||||||||||
Derivatives Not Designated as Hedging Instruments (3) | |||||||||||||||
Foreign currency contracts | $ | $ | $ | $ | ( | ) |
(1) |
(2) |
(3) |
Changes in Accumulated Other Comprehensive Income/(Loss) by Component | |||||||||||||||||||
Hedges | Investment Securities | Pension and Other Retiree Benefits | Financial Statement Translation | Total | |||||||||||||||
Balance at June 30, 2017 | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
OCI before reclassifications (1) | ( | ) | ( | ) | ( | ) | |||||||||||||
Amounts reclassified from AOCI (2) | ( | ) | |||||||||||||||||
Net current period OCI | ( | ) | ( | ) | |||||||||||||||
Balance at March 31, 2018 | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) |
(1) |
(2) |
• | Hedges: see Note 7 for classification of gains and losses from hedges in the Consolidated Statements of Earnings. |
• | Investment securities: amounts reclassified from AOCI into Other non-operating income, net. |
• |
Nine Months Ended March 31, 2018 | |||||||||||||||||||||||
Accrual Balance June 30, 2017 | Charges Previously Reported (Six Months Ended December 31, 2017) | Charges for the Three Months Ended March 31, 2018 | Cash Spent | Charges Against Assets | Accrual Balance March 31, 2018 | ||||||||||||||||||
Separations | $ | $ | $ | $ | ( | ) | $ | $ | |||||||||||||||
Asset-related costs | ( | ) | |||||||||||||||||||||
Other costs | ( | ) | |||||||||||||||||||||
Total | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ |
Three Months Ended March 31, 2018 | Nine Months Ended March 31, 2018 | ||||||
Beauty | $ | $ | |||||
Grooming | |||||||
Health Care | |||||||
Fabric & Home Care | |||||||
Baby, Feminine & Family Care | |||||||
Corporate (1) | |||||||
Total Company | $ | $ |
(1) |
Nine Months Ended March 31, 2017 | |||
Net sales | $ | ||
Cost of products sold | |||
Selling, general and administrative expense | |||
Interest expense | |||
Other non-operating income/(expense), net | |||
Earnings/(loss) from discontinued operations before income taxes | ( | ) | |
Income taxes on discontinued operations | |||
Gain on sale of business before income taxes | |||
Income tax expense/(benefit) on sale of business (1) | ( | ) | |
Net earnings from discontinued operations | $ |
(1) |
Nine Months Ended March 31, 2017 | |||
NON-CASH OPERATING ITEMS | |||
Depreciation and amortization | $ | ||
Deferred income tax benefit | ( | ) | |
Before tax gain on sale of businesses | |||
Net increase in accrued taxes | |||
CASH FLOWS FROM OPERATING ACTIVITIES | |||
Cash taxes paid | |||
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Capital expenditures |
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations |
• | Overview |
• | Summary of Results – Nine Months Ended March 31, 2018 |
• | Economic Conditions and Uncertainties |
• | Results of Operations – Three and Nine Months Ended March 31, 2018 |
• | Business Segment Discussion – Three and Nine Months Ended March 31, 2018 |
• | Liquidity and Capital Resources |
• | Reconciliation of Measures Not Defined by U.S. GAAP |
Reportable Segments | Product Categories (Sub-Categories) | Major Brands |
Beauty | Hair Care (Conditioner, Shampoo, Styling Aids, Treatments) | Head & Shoulders, Pantene, Rejoice |
Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care) | Olay, Old Spice, Safeguard, SK-II | |
Grooming | Grooming (1) (Shave Care - Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care; Appliances) | Braun, Fusion, Gillette, Mach3, Prestobarba, Venus |
Health Care | Oral Care (Toothbrushes, Toothpaste, Other Oral Care) | Crest, Oral-B |
Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care) | Prilosec, Vicks | |
Fabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide |
Home Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Febreze, Mr. Clean, Swiffer | |
Baby, Feminine & Family Care | Baby Care (Baby Wipes, Diapers and Pants) | Luvs, Pampers |
Feminine Care (Adult Incontinence, Feminine Care) | Always, Tampax | |
Family Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin |
(1) | The Grooming product category is comprised of the Shave Care and Appliances Global Business Units. |
Three Months Ended March 31 | Nine Months Ended March 31 | ||||||
Net Sales | Net Earnings | Net Sales | Net Earnings | ||||
Beauty | 18% | 21% | 19% | 23% | |||
Grooming | 9% | 15% | 10% | 14% | |||
Health Care | 12% | 13% | 12% | 14% | |||
Fabric & Home Care | 33% | 28% | 32% | 27% | |||
Baby, Feminine & Family Care | 28% | 23% | 27% | 22% | |||
Total Company | 100% | 100% | 100% | 100% |
• | Net sales increased 3% to $50.3 billion. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, increased 1%. Organic sales increased 6% in Beauty, increased 2% in Health Care and increased 3% in Fabric & Home Care. Organic sales decreased 4% in Grooming and decreased 2% in Baby, Feminine & Family Care. |
• | Unit volume increased 1%, with organic volume up 2%. Volume increased low single digits in Beauty, Grooming, Health Care and Fabric & Home Care and decreased low single digits in Baby, Feminine & Family Care. Excluding the impacts of minor brand divestitures, organic volume increased mid-single digits in Fabric & Home Care. |
• | Net earnings from continuing operations were $8.0 billion, unchanged versus the prior year. An increase in earnings before income taxes, driven primarily by sales growth and prior year charges for early debt extinguishment, was offset by an increase in taxes due primarily to the transitional impact of the U.S. Tax Act. |
• | Diluted net earnings per share from continuing operations increased 2% to $2.94 due primarily to a reduction in shares outstanding caused by both cash repurchases and shares acquired as part of the prior year Beauty Brands divestiture. |
• | Net earnings attributable to Procter & Gamble decreased $5.3 billion or 40% versus the prior year period to $7.9 billion. The decline was primarily due to a reduction in earnings from discontinued operations related to the base period gain from Beauty Brands divestiture. |
• | Core net earnings attributable to Procter & Gamble, which represents net earnings from continuing operations, excluding U.S. tax reform transitional impacts, incremental restructuring charges and the base period charge for early extinguishment of debt, increased 4% to $8.8 billion. Core net earnings per share increased 7% to $3.28 due to the increase in core net earnings and the reduction in shares outstanding. |
• | Operating cash flow was $10.7 billion. Free cash flow, which is operating cash flow less capital expenditures, was $7.9 billion. Adjusted free cash flow productivity, which is the ratio of free cash flow to adjusted net earnings, was 91%. |
Three Months Ended March 31 | |||||
Amounts in millions, except per share amounts | 2018 | 2017 | % Chg | ||
Net sales | $16,281 | $15,605 | 4% | ||
Operating income | 3,296 | 3,360 | (2)% | ||
Net earnings from continuing operations | 2,540 | 2,556 | (1)% | ||
Net earnings from discontinued operations | — | — | N/A | ||
Net earnings attributable to Procter & Gamble | 2,511 | 2,522 | —% | ||
Diluted net earnings per common share | 0.95 | 0.93 | 2% | ||
Diluted net earnings per share from continuing operations | 0.95 | 0.93 | 2% | ||
Core net earnings per common share | 1.00 | 0.96 | 4% | ||
Three Months Ended March 31 | |||||
COMPARISONS AS A % OF NET SALES | 2018 | 2017 | Basis Pt Chg | ||
Gross profit | 48.8% | 49.8% | (100) | ||
Selling, general & administrative expense | 28.5% | 28.3% | 20 | ||
Operating income | 20.2% | 21.5% | (130) | ||
Earnings from continuing operations before income taxes | 20.0% | 21.4% | (140) | ||
Net earnings from continuing operations | 15.6% | 16.4% | (80) | ||
Net earnings attributable to Procter & Gamble | 15.4% | 16.2% | (80) |
Net Sales Change Drivers 2018 vs. 2017 (Three Months Ended March 31) (1) | |||||||||||||
Volume with Acquisitions & Divestitures | Volume Excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix | Other (2) | Net Sales Growth | |||||||
Beauty | —% | —% | 5% | (1)% | 6% | —% | 10% | ||||||
Grooming | 3% | 3% | 5% | (3)% | (3)% | —% | 2% | ||||||
Health Care | 3% | 3% | 5% | (2)% | —% | (1)% | 5% | ||||||
Fabric & Home Care | 3% | 4% | 4% | (1)% | —% | —% | 6% | ||||||
Baby, Feminine & Family Care | (2)% | (2)% | 3% | (1)% | —% | —% | —% | ||||||
Total Company | 1% | 2% | 4% | (2)% | 1% | —% | 4% |
• | a 100 basis point decline due to higher commodity costs, |
• | a 110 basis point decline from unfavorable mix, including unfavorable product mix (primarily within segments due to disproportionate growth of lower margin products forms and club channels in certain categories), unfavorable geographic mix in certain categories and approximately 40 basis points of transportation cost hurts, |
• | an 80 basis point decline from reduced pricing and |
• | a 20 basis point decline from unfavorable foreign exchange. |
• | a 250 basis point net reduction from the ongoing impacts of the U.S. Tax Act on current period earnings, |
• | a reduction of approximately 200 basis points from favorable geographic mix of earnings, |
• | a 120 basis point increase from reduced excess tax benefits from share-based compensation (which totaled 60 basis points in the current year versus 180 basis points in the prior year period) and |
• | a 110 basis point increase from reduced favorable discrete impacts related to uncertain tax positions (30 basis points in the current year versus 140 basis points in the prior year period). |
Nine Months Ended March 31 | |||||
Amounts in millions, except per share amounts | 2018 | 2017 | % Chg | ||
Net sales | $50,329 | $48,979 | 3% | ||
Operating income | 11,034 | 11,006 | —% | ||
Net earnings from continuing operations | 7,971 | 7,992 | —% | ||
Net earnings from discontinued operations | — | 5,217 | N/A | ||
Net earnings attributable to Procter & Gamble | 7,859 | 13,111 | (40)% | ||
Diluted net earnings per common share | 2.94 | 4.76 | (38)% | ||
Diluted net earnings per share from continuing operations | 2.94 | 2.87 | 2% | ||
Core net earnings per common share | 3.28 | 3.07 | 7% | ||
Nine Months Ended March 31 | |||||
COMPARISONS AS A % OF NET SALES | 2018 | 2017 | Basis Pt Chg | ||
Gross profit | 49.9% | 50.5% | (60) | ||
Selling, general & administrative expense | 27.9% | 28.0% | (10) | ||
Operating income | 21.9% | 22.5% | (60) | ||
Earnings from continuing operations before income taxes | 21.9% | 21.1% | 80 | ||
Net earnings from continuing operations | 15.8% | 16.3% | (50) | ||
Net earnings attributable to Procter & Gamble | 15.6% | 26.8% | (1,120) |
Net Sales Change Drivers 2018 vs. 2017 (Nine Months Ended March 31) (1) | |||||||||||||
Volume with Acquisitions & Divestitures | Volume Excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix | Other (2) | Net Sales Growth | |||||||
Beauty | 1% | 1% | 2% | —% | 5% | —% | 8% | ||||||
Grooming | 1% | 1% | 3% | (3)% | (2)% | —% | (1)% | ||||||
Health Care | 2% | 2% | 3% | (1)% | 1% | —% | 5% | ||||||
Fabric & Home Care | 3% | 4% | 2% | (1)% | —% | —% | 4% | ||||||
Baby, Feminine & Family Care | (1)% | (1)% | 1% | (1)% | —% | —% | (1)% | ||||||
Total Company | 1% | 2% | 2% | (1)% | 1% | —% | 3% |
• | a 90 basis point decline due to higher commodity costs, |
• | a 40 basis point decline from unfavorable product mix (within segments due to disproportionate growth of lower margin product forms, large sizes and club channels and between segments caused by the disproportionate volume growth in Fabric & Home Care, which has lower than company-average gross margin), |
• | a 30 basis point decline from unfavorable foreign exchange and |
• | a 50 basis point decline from the impact of reduced pricing. |
• | a 370 basis-point reduction from the ongoing impacts of the U.S. Tax Act, as the impact of the lower blended U. S. federal rate on current year earnings versus prior year was partially offset by reduced foreign tax credits versus prior year due to the inability to fully credit foreign taxes under the U.S. Tax Act, |
• | a reduction of approximately 40 basis-points from favorable geographic mix of earnings, |
• | a 150 basis-point increase from reduced favorable discrete impacts related to uncertain tax positions (which totaled 20 basis points in the current year versus 170 basis points in the prior year), |
• | a 120 basis-point increase from reduced excess tax benefits from share-based compensation (60 basis points in the current year versus 180 basis points in the prior year) and |
• | a 70 basis-point increase from the tax impacts of the prior year extinguishment of long-term debt. |
Three Months Ended March 31, 2018 | ||||||||||||||||||||
Net Sales | % Change Versus Year Ago | Earnings/(Loss) from Continuing Operations Before Income Taxes | % Change Versus Year Ago | Net Earnings/(Loss) from Continuing Operations | % Change Versus Year Ago | |||||||||||||||
Beauty | $ | 2,934 | 10 | % | $ | 642 | 21 | % | $ | 488 | 23 | % | ||||||||
Grooming | 1,550 | 2 | % | 422 | (3 | )% | 334 | — | % | |||||||||||
Health Care | 1,934 | 5 | % | 467 | (1 | )% | 305 | (2 | )% | |||||||||||
Fabric & Home Care | 5,262 | 6 | % | 1,001 | 3 | % | 635 | 6 | % | |||||||||||
Baby, Feminine & Family Care | 4,458 | — | % | 852 | (4 | )% | 539 | (3 | )% | |||||||||||
Corporate | 143 | 5 | % | (131 | ) | N/A | 239 | N/A | ||||||||||||
Total Company | $ | 16,281 | 4 | % | $ | 3,253 | (2 | )% | $ | 2,540 | (1 | )% |
Nine Months Ended March 31, 2018 | ||||||||||||||||||||
Net Sales | % Change Versus Year Ago | Earnings/(Loss) from Continuing Operations Before Income Taxes | % Change Versus Year Ago | Net Earnings/(Loss) from Continuing Operations | % Change Versus Year Ago | |||||||||||||||
Beauty | $ | 9,305 | 8 | % | $ | 2,331 | 15 | % | $ | 1,775 | 16 | % | ||||||||
Grooming | 4,903 | (1 | )% | 1,367 | (13 | )% | 1,086 | (11 | )% | |||||||||||
Health Care | 6,048 | 5 | % | 1,590 | 1 | % | 1,065 | 1 | % | |||||||||||
Fabric & Home Care | 16,079 | 4 | % | 3,281 | 2 | % | 2,118 | 3 | % | |||||||||||
Baby, Feminine & Family Care | 13,616 | (1 | )% | 2,749 | (8 | )% | 1,766 | (9 | )% | |||||||||||
Corporate | 378 | (1 | )% | (281 | ) | N/A | 161 | N/A | ||||||||||||
Total Company | $ | 50,329 | 3 | % | $ | 11,037 | 7 | % | $ | 7,971 | — | % |
• | Volume in Hair Care decreased low single digits. Developed market volume decreased mid-single digits due to competitive activity. Volume in developing regions increased low single digits due to product innovation and market growth. Global market share of the Hair Care category decreased half a point. |
• | Volume in Skin and Personal Care increased low single digits. Volume increased low single digits in developed regions due to product innovation. Volume increased mid-single digits in developing regions due to increased marketing spending and product innovation. Global market share of the Skin and Personal Care category was unchanged. |
• | Volume in Hair Care was unchanged. Volume in developed regions decreased low single digits due to competitive activity. Volume in developing regions increased low single digits due to product innovation and improved in-store executions. Global market share of the Hair Care category decreased slightly. |
• | Volume in Skin and Personal Care increased low single digits. Volume increased low single digits in developed regions driven by product innovation partially offset by reduced shipments following increased pricing. Volume increased mid-single digits in developing regions due to product innovation and increased marketing. Global market share of the Skin and Personal Care category was unchanged. |
• | Shave Care volume increased low single digits. Developed regions volume increased low single digits due to increased price competitiveness following price reductions and product innovation. Developing regions volume increased mid-single digits due to lower pricing in the form of higher promotional spending. Global market share of the Shave Care category was unchanged. |
• | Volume in Appliances decreased low single digits. Volume decreased mid-single digits in developed regions due to trade inventory reductions and a base period that was up double digits due to innovation. Volume increased high single digits in developing regions due to product innovation and market growth. Global market share of the Appliances category increased more than a point. |
• | Volume in Shave Care was unchanged. Volume in developed regions increased low single digits due to increased competitiveness following price reductions and product innovation. Volume in developing regions was unchanged. Global market share of the Shave Care category decreased less than half a point. |
• | Volume in Appliances increased double digits in both developed and developing regions due to product innovation. Global market share of the Appliances category increased more than a point. |
• | Oral Care volume increased low single digits. Volume decreased low single digits in developed regions due to trade inventory reductions and competitive activity. Volume increased low single digits in developing regions due to product innovation and increased promotional competitiveness. Global market share of the Oral Care category decreased half a point. |
• | Volume in Personal Health Care increased high single digits. Volume increased high single digits in developed regions due to increased consumption from a strong Cough / Cold season and product innovation. Volume in developing regions increased high single digits and double digits on organic basis, due to product innovation and increased consumption from a strong Cough / Cold season. Excluding the impact of minor brand divestitures, organic volume grew double digits. Global market share of the Personal Health Care category increased less than half a point. |
• | Oral Care volume increased low single digits. Volume in developed regions increased low single digits driven by product innovation and marketing investments on premium power brush segment. Volume in developing regions was unchanged. Global market share of the Oral Care category decreased less than half a point. |
• | Volume in Personal Health Care increased mid-single digits. Volume increased low single digits in developed regions and high single digits in developing regions due to increased consumption from a strong Cough / Cold season and product innovation. Global market share of the Personal Health Care category increased less than half a point. |
• | Fabric Care volume increased low single digits. Excluding the impact of minor brand divestitures, volume increased mid-single digits. Volume in developed regions grew mid-single digits due to product innovation and lower pricing in the form of increased promotional spending. Volume in developing regions decreased low single digits. Excluding the impact of minor brand divestitures, developing regions volume increased low single digits driven by product innovation. Global market share of the Fabric Care category increased slightly. |
• | Home Care volume increased mid-single digits. Volume in developed and developing regions increased mid-single digits due to product innovation, increased marketing and category growth. Global market share of the Home Care category was unchanged. |
• | Fabric Care volume increased low single digits. Excluding the impact of minor brand divestitures, volume increased mid-single digits. Volume in developed regions grew mid-single digits due to product innovation and lower pricing in the form of increased promotional spending. Volume in developing regions grew low single digits due to product innovation and market growth. Global market share of the Fabric Care category increased slightly. |
• | Home Care volume increased mid-single digits. Volume in developed regions increased low single digits due to product innovation and increased marketing. Volume in developing regions increased mid-single digits due to product innovation, marketing investments and category growth. Global market share of the Home Care category was unchanged. |
• | Volume in Baby Care decreased mid-single digits. Volume in developed regions declined low single digits due to trade inventory reductions and competitive activity. Volume in developing regions declined high single digits due to competitive activity including lower competitor pricing in certain markets. Global market share of the Baby Care category decreased more than a point. |
• | Volume in Feminine Care decreased low single digits. Organic volume, which excludes the impact of minor brand divestitures, increased low single digits. Volume in developed regions declined low single digits, but increased low single digits on an organic basis due to product innovation and adult incontinence category growth. Volume increased low single digits in developing regions driven by product innovation and increased promotional spending. Global market share of the Feminine Care category increased slightly. |
• | Volume in Family Care, which is predominantly a North American business, was unchanged as the impacts of product innovation and distribution gains was offset by trade inventory reductions. In the U.S., all-outlet share of the Family Care category was unchanged. |
• | Baby Care volume decreased mid-single digits. Volume in developed regions declined low single digits due to competitive activities and trade inventory reductions. Volume in developing regions declined high single digits due to competitive activity, reduced shipments following increased pricing and a reduction in trade inventories. Global market share of the Baby Care category decreased more than a point. |
• | Feminine Care volume decreased low single digits. Organic volume, which excludes the impact of minor brand divestitures, increased low single digits. Organic volume increased low single digits in developed regions due to product innovation. Volume increased low single digits in developing regions due to product innovation and market growth. Global market share of the Feminine Care category was unchanged. |
• | Family Care volume increased low single digits, driven by product innovation and distribution gains. In the U.S., all-outlet share of the Family Care category was unchanged. |
Three Months Ended March 31, 2018 | Net Sales Growth | Foreign Exchange Impact | Acquisition & Divestiture Impact/Other (1) | Organic Sales Growth | |||
Beauty | 10% | (5)% | —% | 5% | |||
Grooming | 2% | (5)% | —% | (3)% | |||
Health Care | 5% | (5)% | 1% | 1% | |||
Fabric & Home Care | 6% | (4)% | 1% | 3% | |||
Baby, Feminine & Family Care | —% | (3)% | —% | (3)% | |||
Total Company | 4% | (4)% | 1% | 1% |
Nine Months Ended March 31, 2018 | Net Sales Growth | Foreign Exchange Impact | Acquisition & Divestiture Impact/Other (1) | Organic Sales Growth | |||
Beauty | 8% | (2)% | —% | 6% | |||
Grooming | (1)% | (3)% | —% | (4)% | |||
Health Care | 5% | (3)% | —% | 2% | |||
Fabric & Home Care | 4% | (2)% | 1% | 3% | |||
Baby, Feminine & Family Care | (1)% | (1)% | —% | (2)% | |||
Total Company | 3% | (2)% | —% | 1% |
Fiscal Year-to-Date, March 31, 2018 | ||||
Operating Cash Flow | Capital Spending | Free Cash Flow | ||
$10,668 | $(2,810) | $7,858 |
Fiscal Year-to-Date, March 31, 2018 | ||||||
Free Cash Flow | Net Earnings | Net U.S. Tax Reform Charge | Adjusted Net Earnings | Adjusted Free Cash Flow Productivity | ||
$7,858 | $7,971 | $650 | $8,621 | 91% |
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures | ||||||||||||||
Three Months Ended March 31, 2018 | ||||||||||||||
AS REPORTED (GAAP) | INCREMENTAL RESTRUCTURING | TRANSITIONAL IMPACTS OF U.S. TAX REFORM | ROUNDING | NON-GAAP (CORE) | ||||||||||
COST OF PRODUCTS SOLD | 8,343 | (110 | ) | — | (1 | ) | 8,232 | |||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE | 4,642 | (28 | ) | — | — | 4,614 | ||||||||
OPERATING INCOME | 3,296 | 138 | — | 1 | 3,435 | |||||||||
INCOME TAX ON CONTINUING OPERATIONS | 713 | 22 | (22 | ) | (1 | ) | 712 | |||||||
NET EARNINGS ATTRIBUTABLE TO P&G | 2,511 | 116 | 22 | — | 2,649 | |||||||||
Core EPS | ||||||||||||||
DILUTED NET EARNINGS PER COMMON SHARE (1) | 0.95 | 0.04 | 0.01 | — | 1.00 |
CHANGE VERSUS YEAR AGO | |||||||
CORE EPS | 4 | % |
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures | |||||||||||
Three Months Ended March 31, 2017 | |||||||||||
AS REPORTED (GAAP) | INCREMENTAL RESTRUCTURING | ROUNDING | NON-GAAP (CORE) | ||||||||
COST OF PRODUCTS SOLD | 7,836 | (113 | ) | 1 | 7,724 | ||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE | 4,409 | 22 | (1 | ) | 4,430 | ||||||
OPERATING INCOME | 3,360 | 91 | — | 3,451 | |||||||
INCOME TAX ON CONTINUING OPERATIONS | 780 | 21 | (1 | ) | 800 | ||||||
NET EARNINGS ATTRIBUTABLE TO P&G | 2,522 | 70 | — | 2,592 | |||||||
Core EPS: | |||||||||||
DILUTED NET EARNINGS PER COMMON SHARE (1) | 0.93 | 0.03 | — | 0.96 |
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures | ||||||||||||||
Nine Months Ended March 31, 2018 | ||||||||||||||
AS REPORTED (GAAP) | INCREMENTAL RESTRUCTURING | TRANSITIONAL IMPACTS OF U.S. TAX REFORM | ROUNDING | NON-GAAP (CORE) | ||||||||||
COST OF PRODUCTS SOLD | 25,239 | (296 | ) | — | — | 24,943 | ||||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE | 14,056 | (9 | ) | — | (1 | ) | 14,046 | |||||||
OPERATING INCOME | 11,034 | 305 | — | 1 | 11,340 | |||||||||
INCOME TAX ON CONTINUING OPERATIONS | 3,066 | 63 | (650 | ) | (1 | ) | 2,478 | |||||||
NET EARNINGS ATTRIBUTABLE TO P&G | 7,859 | 242 | 650 | — | 8,751 | |||||||||
Core EPS | ||||||||||||||
DILUTED NET EARNINGS PER COMMON SHARE (1) | 2.94 | 0.09 | 0.24 | 0.01 | 3.28 |
CHANGE VERSUS YEAR AGO | |||||||
CORE EPS | 7 | % |
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures | |||||||||||||||||
Nine Months Ended March 31, 2017 | |||||||||||||||||
AS REPORTED (GAAP) | DISCONTINUED OPERATIONS | INCREMENTAL RESTRUCTURING | EARLY DEBT EXTINGUISHMENT | ROUNDING | NON-GAAP (CORE) | ||||||||||||
COST OF PRODUCTS SOLD | 24,236 | — | (352 | ) | — | 1 | 23,885 | ||||||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE | 13,737 | — | 81 | — | (1 | ) | 13,817 | ||||||||||
OPERATING INCOME | 11,006 | — | 271 | — | — | 11,277 | |||||||||||
INCOME TAX ON CONTINUING OPERATIONS | 2,338 | — | 57 | 198 | (1 | ) | 2,592 | ||||||||||
NET EARNINGS ATTRIBUTABLE TO P&G | 13,111 | (5,217 | ) | 214 | 345 | — | 8,453 | ||||||||||
Core EPS: | |||||||||||||||||
DILUTED NET EARNINGS PER COMMON SHARE (1) | 4.76 | (1.89 | ) | 0.08 | 0.13 | (0.01 | ) | 3.07 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Item 4. | Controls and Procedures |
Item 1. | Legal Proceedings |
Item 1A. | Risk Factors |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
Period | Total Number of Shares Purchased (1) | Average Price Paid per Share (2) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3) | Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program | |||||
1/01/2018 - 1/31/2018 | 5,542,840 | $90.21 | 5,542,840 | (3) | |||||
2/01/2018 - 2/28/2018 | 5,493,529 | $81.91 | 5,493,529 | (3) | |||||
3/01/2018 - 3/31/2018 | 5,463,282 | $78.70 | 5,463,282 | (3) | |||||
Total | 16,499,651 | $83.63 | 16,499,651 |
(1) | All transactions were made in the open market with large financial institutions. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless exercises. |
(2) | Average price paid per share for open market transactions is calculated on a settlement basis and excludes commission. |
(3) | On April 19, 2018, the Company stated that in fiscal year 2018 the Company expects to reduce outstanding shares through direct share repurchases at a value of approximately $6 to $8 billion, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and are expected to be financed by a combination of operating cash flows and issuance of long-term and short-term debt. |
Item 6. | Exhibits |
3-1 | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016) | ||
3-2 | Regulations (as approved by the Board of Directors on April 8, 2016, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-K for the year ended June 30, 2016) | ||
10-1 | Company’s Form of Separation Agreement and Release * + | ||
10-2 | Company’s Form of Separation Letter and Release * + | ||
12 | Computation of Ratio of Earnings to Fixed Charges + | ||
31.1 | Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer + | ||
31.2 | Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer + | ||
32.1 | Section 1350 Certifications – Chief Executive Officer + | ||
32.2 | Section 1350 Certifications – Chief Financial Officer + | ||
101.INS (1) | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||
101.SCH (1) | XBRL Taxonomy Extension Schema Document | ||
101.CAL (1) | XBRL Taxonomy Extension Calculation Linkbase Document | ||
101.DEF (1) | XBRL Taxonomy Definition Linkbase Document | ||
101.LAB (1) | XBRL Taxonomy Extension Label Linkbase Document | ||
101.PRE (1) | XBRL Taxonomy Extension Presentation Linkbase Document |
* | Compensatory plan or arrangement |
+ | Filed herewith |
(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. |
THE PROCTER & GAMBLE COMPANY | ||||
April 19, 2018 | /s/ VALARIE L. SHEPPARD | |||
Date | (Valarie L. Sheppard) | |||
Senior Vice President, Comptroller and Treasurer |
Exhibit | ||
101.INS (1) | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH (1) | XBRL Taxonomy Extension Schema Document | |
101.CAL (1) | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF (1) | XBRL Taxonomy Definition Linkbase Document | |
101.LAB (1) | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE (1) | XBRL Taxonomy Extension Presentation Linkbase Document |
+ | Filed herewith |
(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. |
Last Day of Employment: | Your last day of employment will be «Exit_Date», referred to as your “Last Day of Employment.” Unless otherwise noted below, your pay and benefits will cease as of your Last Day of Employment. |
Separation Payment: | As soon as administratively practical after your Last Day of Employment, P&G will provide you with a Separation Payment of «Total_Amount», less legally required withholdings and deductions. In no event will payment be made before expiration of the seven-day revocation period discussed below or later than the March 15th of the year following the year which includes your last day of employment. Amounts you owe to P&G as of your Last Day of Employment, including, but not limited to, wage and/or benefit overpayments and unpaid loans, will also be deducted from the Separation Payment. |
STAR Awards: | As of your Last Day of Employment, if you worked at least 28 days (4 calendar weeks) during that fiscal year, you will receive a pro-rated STAR award for that fiscal year. Your STAR award will be pro-rated by dividing the number of calendar days during the fiscal year from July 1 through your Last Day of Employment by 365. Your STAR award will be paid in cash in the September (but no later than September 15th) immediately following the end of the fiscal year in which you terminate. |
Equity Awards | Your separation will be treated as a Special Separation for purposes of any outstanding equity awards granted under the Procter & Gamble 2009 Stock and Incentive Compensation Plan, the Procter & Gamble 2001 Stock and Incentive Compensation Plan, the Procter & Gamble 1992 Stock Plan, or the Gillette Company 2004 Long-Term Incentive Plan and as a result the awards will be retained subject to the original terms and conditions of the awards. Awards granted under the Procter & Gamble 2014 Stock & Incentive Compensation Plan are retained subject to the terms and conditions of the Awards. This agreement does not alter the rights and obligations that you may have under the Procter & Gamble 2014 Stock & Incentive compensation Plan, the Procter & Gamble 2009 Stock and Incentive Compensation Plan, the Procter & Gamble 2001 Stock and Incentive Plan, the Procter & Gamble 1992 Stock Plan, and the Gillette Company 2004 Long-Term Incentive Plan. |
Current Medical, Dental, and Life Insurance Benefits | Your Medical (including prescription drug and EAP programs), Dental, and Basic Group Life insurance coverage will continue under the same terms until «Benefits_End_Date». When your extended coverage ends, you may be entitled to continue your Medical and Dental insurance coverage under COBRA. If you are entitled to COBRA continuation coverage, you will receive a notice of your right to elect COBRA. |
[Optional if applicable] Current Medical, Dental, and Life Insurance Benefits: | [Your coverage under the P&G International Health Plan for Expatriates (including medical, prescription drug, and dental coverage) and Basic Group Life insurance coverage will continue under the same terms until «Benefits_End_Date».] |
Retiree Medical and Dental Benefits 1: | If you were eligible for P&G retiree healthcare coverage on your Last Day of Employment, you will be eligible to enroll in P&G’s retiree medical and dental insurance coverage. You are eligible for P&G retiree healthcare coverage if you satisfy the regular retiree eligibility rules (i.e., you are a Regular Retiree) as of your Last Day of Employment. Under the terms of this Agreement, you also are eligible for P&G retiree healthcare coverage as a Special Retiree by satisfying the Rule of 70 as of your Last Day of Employment. You satisfy the Rule of 70 when your full years of age plus your full years of service equal 70. Special rules apply to Gillette Heritage Employees with regard to retiree medical eligibility and the retiree medical cost sharing under the retiree medical plan. If you are a Gillette Heritage Employee, you will receive a separate handout on your retiree medical eligibility. If you are eligible for P&G’s retiree healthcare coverage as either a Regular Retiree or a Special Retiree as of your Last Day of Employment, you should contact the Employee Service Center before your extension of coverage ends to request retiree healthcare enrollment information. For details regarding the terms and conditions of your retiree health coverage, please refer to and review the summary plan descriptions, available at PGOneLife and Career. Important Note: If you become employed by a direct competitor of P&G (as determined by P&G’s Chief Human Resources Officer) in any capacity, you will not be eligible for coverage under P&G’s retiree healthcare coverage as long as you remain employed by such competitor. If you have questions, please contact the Benefits Service Center at 1-888-627-7472. |
[Optional if applicable] Retiree Medical and Dental Benefits: | [As an employee who “localized” to the United States pursuant to a P&G-initiated localization, you will be eligible for coverage under the P&G International Health Plan for Retirees if you satisfy the criteria for being a “Regular Retiree” or a “Special Retiree” as on your Last Day of Employment and you are prohibited from legally being a permanent resident in the United States after you retire from P&G. However, if you are (a) eligible for health care coverage that is sponsored by another employer, or (b) enrolled in other P&G-sponsored health coverage, you will not be eligible for coverage under the P&G International Health Plan for Retirees until you are no longer eligible for or enrolled in such other coverage, respectively. If you are eligible for coverage under the P&G International Health Plan for Retirees, you should contact U.S. Benefits Services (888-627-7472) before your extension of coverage ends to request information on how to enroll in that coverage. For details regarding the terms and conditions of coverage under the P&G International Health Plan for Retirees (including the definitions of “Regular Retiree” and “Special Retiree,” please refer to and review the summary plan description for the P&G International Health Plan for Retirees. To request a copy of the summary plan description, contact your concierge service representative.] |
Outplacement Services: | P&G’s outplacement supplier, Right Management Consultants, will provide services to assist you in managing your transition to a new future, based on your interest. Services include pre-decision counseling, career transition programs, and job development opportunities. Right Management Consultants will also assist you in preparing for your job search, including résumé preparation, cover letters, other written materials and interview and networking training. After you accept this Agreement, you may begin utilizing outplacement services on a limited basis prior to your Last Day of Employment, consistent with the needs of the business and your responsibilities to complete and/or transition your work. Note that you must begin utilizing outplacement services within 45 days of your Last Day of Employment to be eligible for this benefit. |
No Consideration Without Executing this Agreement: | You affirm that you understand and agree that you would not receive the separation payment and/or benefits specified in this Agreement without executing this Agreement and fulfilling the promises contained in it. Except as provided in this Agreement or under the terms and conditions of an applicable benefit plan or policy sponsored by P&G, you shall not be due any payments or benefits from P&G in connection with the termination of your employment. |
Continued Employment Through Your Last Day of Employment: | You agree to perform your work and responsibilities as an employee in a satisfactory manner up to and including your Last Day of Employment, including compliance with all provisions of this “Separation Agreement and Release.” If P&G determines that you have engaged in serious misconduct during your employment, you understand and agree that P&G may terminate your employment immediately and will not provide, nor will it be obligated to provide, you with the Separation Payment, medical benefits, outplacement and other benefits described above. If you have already received any such pay or benefits, you agree to repay them to P&G upon demand. |
1 Special rules apply to Gillette Heritage Employees with regard to retiree medical eligibility and the retiree medical cost sharing under the retiree medical plan. If you are a Gillette Heritage Employee, you will receive a separate handout on your retiree medical eligibility. |
Nonadmission of Wrongdoing: | You affirm that you understand and agree that neither this Agreement nor the furnishing of the consideration for this Agreement, including the Separation Payment, shall be deemed or construed at any time for any purpose as an admission by P&G of wrongdoing or evidence of any liability or unlawful conduct of any kind. |
Release of Claims - Including Age Discrimination and Employment Claims: | In consideration of the Separation Payment and other benefits provided above to which you would not have been entitled under any existing P&G Policy, you release P&G from any and all claims you have against P&G. The term “P&G” includes «Company» and any of its present, former and future owners, parents, affiliates and subsidiaries, and its and their directors, officers, shareholders, employees, agents, servants, representatives, predecessors, successors and assigns and their employee benefit plans and programs and their administrators and fiduciaries. This release applies to claims about which you now know or may later discover, and includes but is not limited to: (1) claims arising under the Age Discrimination in Employment Act, 29 U.S.C. § 621, et seq.; (2) claims arising out of or relating in any way to your employment with P&G or the conclusion of that employment; (3) claims arising under any federal, state and local employment discrimination laws, regulations or ordinances or other orders that relate to the employment relationship and/or employee benefits; and (4) any other federal, state or local law, rule, regulation or ordinance, public policy, contract, tort or common law. This release does not apply to claims that may arise after the date you accept this Agreement or that may not be released under applicable law. You are not waiving any rights you may have to: (a) your own vested accrued employee benefits under the P&G health, welfare, or retirement benefit plans as of the Last Day of Employment; (b) benefits and/or the right to seek benefits under applicable workers’ compensation and/or unemployment compensation statutes; (c) pursue claims which by law cannot be waived by signing this Agreement; (d) enforce this Agreement; and/or (e) challenge the validity of this Agreement. You agree that the decision as to what would be your Last Day of Employment was made prior to your accepting and executing this Agreement, and you agree that you are releasing any claim in connection with the separation of your employment. If any claim is not subject to release, to the extent permitted by law, you agree that you waive any right or ability to be a class or collective action representative or to otherwise participate in any putative or certified class, collective or multi-party action or proceeding based on such a claim in which P&G is a party. Governmental Agencies: Nothing in this Separation Letter & Release prohibits or prevents you from filing a charge with or participating, testifying, or assisting in any investigation, hearing, or other proceeding before the U.S. Equal Employment Opportunity Commission, the National Labor Relations Board or a similar agency enforcing federal, state or local anti-discrimination laws. However, to the maximum extent permitted by law, you agree that if such an administrative claim is made to such an anti-discrimination agency, you shall not be entitled to recover any individual monetary relief or other individual remedies. Nothing in this Separation Letter & Release prohibits you from: (1) reporting possible violations of federal law or regulations, including any possible securities laws violations, to any governmental agency or entity, including but not limited to the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Congress, or any agency Inspector General; (2) making any other disclosures that are protected under the whistleblower provisions of federal law or regulations; or (3) otherwise fully participating in any federal whistleblower programs, including but not limited to any such programs managed by the U.S. Securities and Exchange Commission and/or the Occupational Safety and Health Administration. You understand you do not need the prior authorization from the Company to make any such reports or disclosures, and you are not required to notify the Company that you have made such reports or disclosures. Moreover, nothing in this Separation Letter & Release prohibits or prevents you from receiving individual monetary awards or other individual relief by virtue of participating in such federal whistleblower programs. |
Confidential, Proprietary, Trade Secret Information & Period of Non-Competition: | Subject to the “Governmental Agencies” portion of the “Release of Claims - Including Age Discrimination and Employment Claims” above, you agree that you will not use or share any confidential, proprietary or trade secret information about any aspect of P&G’s business with any non-P&G employee or business entity at any time in the future. You further agree that you will not obtain or have in your possession any confidential, proprietary or trade secret information on or after your last day of employment. Confidential, proprietary or trade secret information includes, but is not limited to, marketing and advertising plans, pricing information, upstream plans, specific areas of research and development, project work, product formulation, processing methods, assignments of individual employees, testing and evaluation procedures, cost figures, construction plans, and special techniques or methods of any kind. Notwithstanding the requirements of confidentiality contained in this section, the federal Defend Trade Secrets Act of 2016 immunizes you against criminal and civil liability under federal or state trade secret laws for your disclosure of trade secrets that is made i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney solely for the purpose of reporting or investigating a suspected violation of law; ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; or iii) to your attorney for use in a lawsuit alleging retaliation for reporting a suspected violation of law, provided that any document containing the trade secret is filed under seal and you do not otherwise disclose the trade secret, except pursuant to court order. You further understand and agree that, unless you have prior written consent from P&G, you will not engage in any activity or provide any services for a period of three (3) years following your Last Day of Employment in connection with the manufacture, development, advertising, promotion or sale of any product which is the same as, similar to, or competitive with any products of P&G or its subsidiaries (including both existing products as well as products in development which are known to you, as a consequence of your employment with P&G): |
1. With respect to which your work has been directly concerned at any time during the two (2) years preceding your Last Day of Employment; or2. With respect to which during that period of time you, as a consequence of your job performance and duties, acquired knowledge of trade secrets or other confidential information of P&G. | |
For the purposes of this section, it shall be conclusively presumed that you have knowledge or information to which you were directly exposed through the actual receipt of memos or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed. The provisions of this section are not in lieu of, but are in addition to, your continuing obligation to not use or disclose P&G’s trade secrets and confidential information known to you until any particular trade secret or confidential information becomes generally known (through no fault of yours). Information regarding products in development, in test market or being marketed or promoted in a discrete geographic region, which information P&G is considering for a broader use, shall not be deemed generally known until such broader use is actually commercially implemented. Also, “generally known” means known throughout the domestic United States industry or, if you have job responsibilities outside of the United States, the appropriate foreign country or countries’ industry. If any restriction in this section is found by any court of competent jurisdiction or arbitrator to be unenforceable because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it will be modified and interpreted to extend only over the maximum period of time, range of activities or geographic area so that it may be enforceable. As a participant in the 2009 Stock and Incentive Compensation Plan, the 2001 Stock and Incentive Compensation Plan, or the 1992 Stock Plan, you are also bound by the terms of Article F - Restrictions & Covenants of those plans, which are incorporated herein by reference. If you are a participant in the 2014 Stock & Incentive Compensation Plan, you are also bound by the terms of Article 6 - Restrictions and Covenants of this plan which are incorporated herein by reference. |
Non-Solicitation | You acknowledge, as a participant in the Procter & Gamble 2014 Stock & Incentive Compensation Plan, the Procter & Gamble 2009 Stock and Incentive Compensation Plan, the Procter & Gamble 2001 Stock and Incentive Plan, the Procter & Gamble 1992 Stock Plan, and/or the Gillette Company 2004 Long-Term Incentive Plan that you are bound to comply with the Plans’ non-solicitation obligations. Specifically, you agree that you will not, at any time following your Employment Separation Date, attempt to directly or indirectly induce any employee of P&G or its affiliates or subsidiaries to be employed or perform services elsewhere or attempt directly or indirectly to solicit the trade or business of any current or prospective customer, supplier or partner of P&G or its affiliates or subsidiaries. |
Acknowledgements and Affirmations: | Subject to the “Governmental Agencies” portion of the “Release of Claims - Including Age Discrimination and Employment Claims” above, you affirm that you have not filed, caused to be filed, or presently are a party to any claim against P&G. You affirm that you have been paid and/or have received all compensation, wages, bonuses, commissions, and/or benefits which are due and payable as of the date you sign this Agreement. To the extent that you are required to report hours worked, you affirm that you have reported all hours worked as of the date you sign this Agreement. You affirm that you have been granted any leave to which you were entitled under the Family and Medical Leave Act or related state or local leave or disability accommodation laws. You further affirm that you have no known workplace injuries or occupational diseases that have not been reported. |
Assignment of Intellectual Property: | You will promptly and fully disclose, transfer and assign to P&G all inventions and any other intellectual property (collectively “Intellectual Property”) made or conceived by you during your employment with P&G. You agree to fully cooperate in executing any papers required for establishing or protecting the Intellectual Property and for establishing P&G’s ownership, even if such cooperation is necessary after your Last Day of Employment. |
Return of P&G Property: | You agree that on or before your Last Day of Employment, you will return to P&G in good condition all of its equipment, materials and information that were in your possession, custody or control (including, but not limited to, computers, files, documents, credit cards, keys and identification badges). You further agree that you will provide your manager with all passwords to P&G electronic communication and data systems before your Last Day of Employment. You further agree that on or before your Last Day of Employment, you will return or if directed to do so by your immediate manager, delete (i.e., destroy all copies of) any and all P&G confidential, proprietary or trade secret information you have maintained in your possession, custody, or control in paper, electronic and/or digital formats, including but not limited to, any such confidential, proprietary, or trade secret information (e.g., files, documents, etc.) that you may have electronically or digitally processed or stored on P&G-issued or on personally-owned or maintained digital devices and/or service accounts. Such digital devices and/or service accounts may include, but are not limited to desktop and laptop computers, notebooks, tablets, iPads, mobile phones, smartphones, personal digital assistants (PDAs), USB and flash drives, external hard drives, CDs, DVDs, and/or external file processing or storage provided by cloud service providers such as box.net, dropbox, Google docs, etc. |
Ethics Compliance: | Subject to the “Governmental Agencies” portion of the “Release of Claims - Including Age Discrimination and Employment Claims” above, you agree that you provided P&G all information known to you regarding any violations of the Procter & Gamble Worldwide Business Conduct Manual and/or any other violations of P&G policy or the law. |
Agreement to Arbitrate Disputes: | Resolving any future differences we may have in the courts can take a long time and be expensive. You and P&G therefore agree that the only remedy for all disputes that are not released by this Agreement or that arise out of your employment with or separation from P&G, or any aspect of this Agreement, will be to submit any such disputes (with the exception noted at the end of this section) to final and binding arbitration in accordance with the National Rules for Resolution of Employment Disputes of the American Arbitration Association then in effect. You and P&G agree that the aggrieved party must send written notice of any claim to the other party by certified mail, return receipt requested. Written notice for P&G will be sent to: Secretary, One Procter & Gamble Plaza, Cincinnati, OH 45202, and to you at the most current address shown for you in P&G’s records. The arbitrator will apply Ohio law. At your written request, P&G will reimburse you for all fees and costs charged by the American Arbitration Association and its arbitrator to the extent they exceed the applicable fees and costs that would have been charged by a court of competent jurisdiction had your claim been filed in court. There is one exception to this section. P&G may seek injunctive relief in any court of competent jurisdiction if it has reason to believe that you have violated or are about to violate (1) the terms of the “Confidential, Proprietary, Trade Secret Information & Period of Non-Competition” section above, or (2) if you are a participant in the 2009 Stock and Incentive Compensation Plan, the 2001 Stock and Incentive Compensation Plan, or the 1992 Stock Plan, the terms of Article F - Restrictions & Covenants of those plans or (3) if you are a participant in the 2014 Stock and Incentive Compensation Plan, the terms of Article 6 - Restrictions & Covenants of those plans. |
Severability: | If any court of competent jurisdiction or arbitrator should later find that any portion of this Agreement is invalid, that invalidity will not affect the enforceability of any other portion of this Agreement. |
Employment References: | You understand that P&G’s historical policy is to not provide employment references to prospective employers. However, P&G is willing to waive that policy in your case on the following basis: You authorize your manager or human resources representative to provide an employment reference upon written or verbal request. In return, you release any claim against P&G and will not bring a lawsuit in court against P&G based upon that employment reference (or lack thereof). You agree that you will refer all reference inquiries to your manager or human resources representative only. You further understand that all disputes regarding employment references or the lack thereof must be resolved through the arbitration process described above. |
No Reliance: | This Agreement sets forth the entire agreement between you and P&G and fully supersedes any prior agreements or understanding between the parties except that if you are a participant in the 2009 Stock and Incentive Compensation Plan, the 2001 Stock and Incentive Compensation Plan, or the 1992 Stock Plan, the terms of Article F - Restrictions & Covenants of those plans remain in full force and effect and are incorporated herein by reference and if you are a participant in the 2014 Stock Plan, the terms of Article 6 - Restrictions & Covenants of the plan remain in full force and are in effect and are incorporated herein by reference. In deciding to accept this Agreement, you agree that you have not relied upon any statements or promises by P&G, its managers, agents or employees, other than those set forth in this Agreement. No other promises or agreements concerning the matters described in this Agreement shall be binding unless in a subsequent document signed by these parties. |
Your Attorney: | You acknowledge that you have been and hereby are advised to consult with legal counsel before accepting this Agreement and have either done so or have voluntarily declined to do so. |
Timing for Acceptance or Revocation: | You have forty-five (45) calendar days in which to consider this Agreement in which you waive important rights, including those under the Age Discrimination in Employment Act of 1967. If you choose to sign this Agreement, please do so by indicating your acceptance of this Agreement with your electronic signature in P&G’s electronic system. We advise you to consult with an attorney of your choosing prior to signing this Agreement. Further, you may within seven (7) calendar days following the date you sign this Agreement, cancel and terminate it by giving written notice of your intention to revoke the Agreement to your immediate manager, and by returning to P&G any remuneration or benefits that have been advanced to you in anticipation of your not revoking your agreement and to which you are not entitled. If notice of your revocation is mailed, it must be postmarked within seven (7) calendar days after you sign this Agreement. You agree that any modifications, material or otherwise, made to this Agreement, do not restart or affect in any manner the original up to forty-five (45) calendar day consideration period. |
Employment Separation Date: | Your last day of employment with P&G will be [ ], which will be your “Employment Separation Date” for purposes of this letter. |
Vacation: | You will receive payment for your accrued but unused vacation as of your Employment Separation Date, which sum will be paid to you in accordance with P&G policy and applicable laws. You will not accrue any additional vacation following your Employment Separation Date. |
STAR Award | As of your Employment Separation Date, if you were otherwise eligible for a STAR award and you worked at least 28 days (4 calendar weeks) during the fiscal year, you will receive a pro-rated STAR award for the fiscal year. Your STAR award will be pro-rated by dividing the number of calendar days during the fiscal year from July 1 through your Employment Separation Date by 365. Your STAR award will be paid in cash in the September (but no later than September 15th) immediately following the end of the fiscal year in which your employment terminates with P&G. |
Separation Payment [Optional]: | P&G will, within thirty (30) calendar days after your Employment Separation Date, provide you with a separation payment in the amount of $[ ] (“Separation Payment”) (representing [ ] weeks of pay at your current salary), less applicable state and federal withholdings and deductions, which sum will be paid in one lump sum payment. The Separation Payment will be the only assistance P&G provides upon your separation. Other resources may be available to you as a participant in general compensation and benefit plans, which it will be your responsibility to identify and make any necessary arrangements upon separation. Amounts you owe to P&G as of your Employment Separation Date, including, but not limited to, wage and/or benefit overpayments and unpaid loans, will also be deducted from the Separation Payment. |
Unemployment Compensation Benefits [Optional]: | Your Separation Payment will be allocated to the [ ] week period following your Employment Separation Date. |
Special Retirement (“Rule of 70”) [Optional]: | P&G will agree to allow the “Rule of 70” to apply to you, but only for purposes of eligibility for retiree health care benefits under the Procter & Gamble Retiree Welfare Benefits Plan. The Rule of 70 is a special eligibility rule for retiree health care coverage (including medical, dental, and prescription drug benefits) under the Procter & Gamble Retiree Welfare Benefits Plan that only applies in specific circumstances. The Rule of 70 will apply to you with respect to health care coverage under the Procter & Gamble Retiree Welfare Benefits Plan as long as that Plan continues to exist and as long as the Rule of 70 continues as an eligibility rule for coverage under that Plan. For purposes of this paragraph only, the parties agree that your employment with P&G ended on [ ], and that you were not terminated for cause. The parties also agree that at the time your employment with the Company ended, you were [ ] years old and had [ ] years of service with the Company, making your full years of age plus full years of service [ ], which is greater than 70. To avoid confusion, other than establishing that the Rule of 70 applies to you for purposes of retiree health care coverage under the Procter & Gamble Welfare Benefits Plan, you are subject to the same terms and conditions of the Procter & Gamble Welfare Benefits Plan, including but not limited to (1) coverage does not begin until you enrolls in the Plan, and once enrolled coverage is only prospective, (2) the monthly premiums required for coverage under the Plan must be paid on time to avoid coverage from terminating, (3) you will become ineligible for coverage under the Plan while you are employed by a direct competitor of P&G (as determined by P&G’s Chief Human Resources Officer) in an officer and/or director capacity (if you were at Band 5 or below at the time your employment with the Company ended) or in any capacity (if you were at Band 6 or above at the time your employment with the Company ended), and (4) the Company’s reservation of amendment and termination rights with respect to the Plan. |
Retention of Vested & Unvested Equity Awards [Optional]: | Your separation will be treated as a Special Separation for purposes of any outstanding equity awards granted under the Procter & Gamble 2009 Stock and Incentive Compensation Plan, the Procter & Gamble 2001 Stock and Incentive Compensation Plan, the Procter & Gamble 1992 Stock Plan, or the Gillette Company 2004 Long-Term Incentive Plan and, as a result, you will retain the awards subject to the original terms and conditions of the awards. You will also retain awards granted under the Procter & Gamble 2014 Stock & Incentive Compensation Plan subject to the terms and conditions of those Awards. This Separation Letter & Release does not alter the rights and obligations that you may have under the Procter & Gamble 2014 Stock & Incentive Compensation Plan, the Procter & Gamble 2009 Stock and Incentive Compensation Plan, the Procter & Gamble 2001 Stock and Incentive Plan, the Procter & Gamble 1992 Stock Plan, and the Gillette Company 2004 Long-Term Incentive Plan. |
Release of Claims - Including Employment Claims: | You hereby release P&G from any and all claims or rights you may have against P&G. The term “P&G” includes The Procter & Gamble Company and any of its present, former and future owners, parents, affiliates and subsidiaries, and its and their directors, officers, shareholders, employees, agents, benefit plans, trustees, fiduciaries, servants, representatives, predecessors, successors and assigns. This release applies to claims about which you now know or may later discover, and includes but is not limited to: (1) claims arising under the Age Discrimination in Employment Act ("ADEA"), 29 U.S.C. § 621, et seq.; (2) claims arising under any other federal, state or local law, regulation or ordinance or other order that regulates the employment relationship and/or employee benefits; and (3) claims arising out of or relating in any way to your employment with P&G or the conclusion of that employment. This release does not apply to claims that may arise after the date you sign this letter or that may not be released under applicable law. |
Governmental Agencies: Nothing in this Separation Letter & Release prohibits or prevents you from filing a charge with or participating, testifying, or assisting in any investigation, hearing, or other proceeding before the U.S. Equal Employment Opportunity Commission, the National Labor Relations Board or a similar agency enforcing federal, state or local anti-discrimination laws. However, to the maximum extent permitted by law, you agree that if such an administrative claim is made to such an anti-discrimination agency, you shall not be entitled to recover any individual monetary relief or other individual remedies. Nothing in this Separation Letter & Release prohibits you from: (1) reporting possible violations of federal law or regulations, including any possible securities laws violations, to any governmental agency or entity, including but not limited to the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Congress, or any agency Inspector General; (2) making any other disclosures that are protected under the whistleblower provisions of federal law or regulations; or (3) otherwise fully participating in any federal whistleblower programs, including but not limited to any such programs managed by the U.S. Securities and Exchange Commission and/or the Occupational Safety and Health Administration. You understand you do not need the prior authorization from the Company to make any such reports or disclosures, and you are not required to notify the Company that you have made such reports or disclosures. Moreover, nothing in this Separation Letter & Release prohibits or prevents you from receiving individual monetary awards or other individual relief by virtue of participating in such federal whistleblower programs. | |
Return of P&G Property: | You agree that by your Employment Separation Date, you will return to P&G in good condition all of its equipment, materials and information that were in your possession, custody or control (including, but not limited to, computers, phones, iPads, tablets files, documents, credit cards, keys and identification badges). You further agree that you will provide your manager with all passwords to P&G electronic communication and data systems before your Employment Separation Date. |
Continuing Cooperation [Optional]: | Regardless of whether you sign this Agreement and in the event it becomes necessary, following your Employment Separation Date, you are required to cooperate in executing any and all papers required for filing and prosecuting any patent applications and establishing P&G’s ownership of all inventions relating to its business which are made by employees hired to invent or create. You understand that you will not receive any additional compensation for such cooperation. |
No Other Agreements: | Except as specifically set forth in this Paragraph (“No Other Agreements”), this letter supersedes any prior written or oral agreements between P&G and you concerning the termination of your employment and any benefits you might receive following that event. This letter is neither a Negotiated Separation Agreement under the Procter & Gamble Basic Separation Program nor an agreement under any other separation program or plan sponsored by The Procter & Gamble Company or any of its subsidiaries. This letter does not alter your rights and obligations under the terms of the P&G Profit Sharing and Employee Stock Ownership Plan, other retirement plans, the P&G Stock and Incentive Compensation Plan, and other compensation plans. |
Years Ended June 30 | Nine Months Ended March 31 | ||||||||||||||||||||||||||
Amounts in millions, except ratio amounts | 2017 | 2016 | 2015 | 2014 | 2013 | 2018 | 2017 | ||||||||||||||||||||
EARNINGS, AS DEFINED | |||||||||||||||||||||||||||
Earnings from operations before income taxes after eliminating undistributed earnings of equity method investees | $ | 13,233 | $ | 13,356 | $ | 11,009 | $ | 13,492 | $ | 13,499 | $ | 11,032 | $ | 10,313 | |||||||||||||
Fixed charges (excluding capitalized interest) | 640 | 778 | 842 | 928 | 900 | 498 | 484 | ||||||||||||||||||||
TOTAL EARNINGS, AS DEFINED | $ | 13,873 | $ | 14,134 | $ | 11,851 | $ | 14,420 | $ | 14,399 | $ | 11,530 | $ | 10,797 | |||||||||||||
FIXED CHARGES, AS DEFINED | |||||||||||||||||||||||||||
Interest expense (including capitalized interest) | $ | 521 | $ | 634 | $ | 693 | $ | 789 | $ | 755 | $ | 409 | $ | 391 | |||||||||||||
1/3 of rental expense | 118 | 144 | 166 | 174 | 171 | 85 | 93 | ||||||||||||||||||||
TOTAL FIXED CHARGES, AS DEFINED | $ | 639 | $ | 778 | $ | 859 | $ | 963 | $ | 926 | $ | 494 | $ | 484 | |||||||||||||
RATIO OF EARNINGS TO FIXED CHARGES | 21.7x | 18.2x | 13.8x | 15.0x | 15.5x | 23.3x | 22.3 |
(1) | I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company; |
(2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
(4) | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ DAVID S. TAYLOR |
(David S. Taylor) |
Chairman of the Board, President and Chief Executive Officer |
April 19, 2018 |
Date |
(1) | I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company; |
(2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
(4) | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ JON R. MOELLER |
(Jon R. Moeller) |
Vice Chairman and Chief Financial Officer |
April 19, 2018 |
Date |
(1) | The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company. |
/s/ DAVID S. TAYLOR |
(David S. Taylor) |
Chairman of the Board, President and Chief Executive Officer |
April 19, 2018 |
Date |
(1) | The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company. |
/s/ JON R. MOELLER |
(Jon R. Moeller) |
Vice Chairman and Chief Financial Officer |
April 19, 2018 |
Date |
DOCUMENT AND ENTITY INFORMATION |
9 Months Ended |
---|---|
Mar. 31, 2018
shares
| |
Document Information [Line Items] | |
Entity Registrant Name | PROCTER & GAMBLE Co |
Entity Central Index Key | 0000080424 |
Current Fiscal Year End Date | --06-30 |
Entity Filer Category | Large Accelerated Filer |
Document Type | 10-Q |
Document Period End Date | Mar. 31, 2018 |
Document Fiscal Year Focus | 2018 |
Document Fiscal Period Focus | Q3 |
Amendment Flag | false |
Trading Symbol | PG |
Entity Well Known Seasoned Issuer | Yes |
Entity Current Reporting Status | Yes |
Entity Voluntary Files | No |
Entity Common Stock, Shares Outstanding | 2,514,599,476 |
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
||||||
Net Sales | $ 16,281 | $ 15,605 | $ 50,329 | $ 48,979 | |||||
Cost of Products Sold | 8,343 | 7,836 | 25,239 | 24,236 | |||||
Selling, General and Administrative Expense | 4,642 | 4,409 | 14,056 | 13,737 | |||||
Operating Income | 3,296 | 3,360 | 11,034 | 11,006 | |||||
Interest Expense | 133 | 96 | 370 | 349 | |||||
Interest Income | 69 | 46 | 184 | 123 | |||||
Other Non-operating Income/(Loss), Net | 21 | 26 | 189 | (450) | |||||
Earnings/(Loss) from Continuing Operations Before Income Taxes | 3,253 | 3,336 | 11,037 | 10,330 | |||||
Income Taxes on Continuing Operations | 713 | 780 | 3,066 | 2,338 | |||||
Net Earnings/(Loss) from Continuing Operations | 2,540 | 2,556 | 7,971 | 7,992 | |||||
Net Earnings/(Loss) from Discontinued Operations | 0 | 0 | 0 | 5,217 | |||||
Net Earnings | 2,540 | 2,556 | 7,971 | 13,209 | |||||
Less: Net Earnings Attributable to Noncontrolling Interest | 29 | 34 | 112 | 98 | |||||
Net Earnings Attributable to Procter & Gamble | $ 2,511 | $ 2,522 | $ 7,859 | $ 13,111 | |||||
Basic Net Earnings Per Common Share | |||||||||
Earnings from Continuing Operations | [1] | $ 0.97 | $ 0.96 | $ 3.02 | $ 2.95 | ||||
Earnings/(Loss) from Discontinued Operations | [1] | 0 | 0 | 0 | 2.00 | ||||
Basic Net Earnings Per Common Share | [1],[2] | 0.97 | 0.96 | 3.02 | 4.95 | ||||
Diluted Net Earnings Per Common Share | |||||||||
Earnings from Continuing Operations | [1] | 0.95 | 0.93 | 2.94 | 2.87 | ||||
Earnings/(Loss) from Discontinued Operations | [1] | 0 | 0 | 0 | 1.89 | ||||
Diluted Net Earnings Per Common Share | [1],[2] | 0.95 | 0.93 | 2.94 | 4.76 | ||||
Dividends Per Common Share | $ 0.6896 | $ 0.6695 | $ 2.0690 | $ 2.0085 | |||||
Diluted Weighted Average Common Shares Outstanding | 2,645.6 | 2,705.5 | 2,668.6 | 2,755.4 | |||||
|
CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
|
Net Earnings | $ 2,540 | $ 2,556 | $ 7,971 | $ 13,209 |
Financial Statement Translation | 925 | 726 | 1,953 | (1,263) |
Unrealized Gains/(Losses) on Hedges | (558) | (192) | (1,188) | 557 |
Unrealized Gains/(Losses) on Investment Securities | (70) | 4 | (135) | (64) |
Unrealized Gains/(Losses) on Defined Benefit Retirement Plans | (17) | 29 | 111 | 722 |
Total Other Comprehensive Income (Loss), Net of Tax | 280 | 567 | 741 | (48) |
Total Comprehensive Income/(Loss) | 2,820 | 3,123 | 8,712 | 13,161 |
Less: Total Comprehensive Income Attributable to Noncontrolling Interest | 29 | 34 | 112 | 98 |
Total Comprehensive Income/(Loss) Attributable to Procter & Gamble | $ 2,791 | $ 3,089 | $ 8,600 | $ 13,063 |
BASIS OF PRESENTATION |
9 Months Ended |
---|---|
Mar. 31, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | Basis of PresentationThese statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017. In the opinion of management, the accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries (the "Company," "Procter & Gamble," "P&G," "we" or "our") contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results. |
NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES |
9 Months Ended |
---|---|
Mar. 31, 2018 | |
Accounting Changes and Error Corrections [Abstract] | |
Accounting Changes and Error Corrections [Text Block] | New Accounting Pronouncements and Policies and U.S. Tax Reform In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)." This guidance outlines a single, comprehensive model for accounting for revenue from contracts with customers. We plan to adopt the standard on July 1, 2018, using the modified retrospective transition method. While we are currently assessing the impact of the new standard, our revenue is primarily generated from the sale of finished product to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. The timing of revenue recognition is not materially impacted by the new standard. The provisions of the new standard may impact the classification of certain payments to customers, moving an immaterial amount of such payments from expense to a deduction from net sales. The impact would reduce net sales by less than 1%. We are still assessing the impact on financial disclosures related to the new standard. We do not expect this new guidance to have any other material impacts on our Consolidated Financial Statements. In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)." The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. We plan to adopt the standard on July 1, 2019. We are currently assessing the impact that the new standard will have on our Consolidated Financial Statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities. In January 2017, the FASB issued ASU 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard simplifies the accounting for goodwill impairment by requiring a goodwill impairment to be measured using a single step impairment model, whereby the impairment equals the difference between the carrying amount and the fair value of the specified reporting units in their entirety. This eliminates the second step of the current impairment model that requires companies to first estimate the fair value of all assets in a reporting unit and measure impairments based on those fair values and a residual measurement approach. It also specifies that any loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. We will adopt the standard no later than July 1, 2020. The impact of the new standard will be dependent on the specific facts and circumstances of future individual impairments, if any. In March 2017, the FASB issued ASU 2017-07, "Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (Topic 715)." This guidance requires an entity to disaggregate the current service cost component from the other components of net benefit costs in the face of the income statement. It requires the service cost component to be presented with other current compensation costs for the related employees in the operating section of the income statement, with other components of net benefit cost presented outside of income from operations. We currently classify all net periodic pension costs within operating costs (as part of Cost of products sold and Selling, general and administrative expense). We will adopt the standard retrospectively no later than July 1, 2018. The adoption of ASU 2017-07 is not expected to have a material impact on our Consolidated Financial Statements. In August 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities." This standard enables entities to better portray the economics of their risk management activities in the financial statements and enhances the transparency and understandability of hedge results through improved disclosures. The new standard is effective for us beginning July 1, 2019, with early adoption permitted. We elected to early adopt the new guidance in the first quarter of fiscal year 2018. The amended presentation and disclosure guidance was applied on a prospective basis. The primary impact of adoption is the required disclosure changes. The adoption of the new standard did not have a material impact on our Consolidated Financial Statements, including the cumulative-effect adjustment required upon adoption. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements. U.S. Tax Reform On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “U.S. Tax Act”). The U.S. Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U. S. corporate income tax rates and implementing a territorial tax system. As the Company has a June 30 fiscal year-end, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal rate of approximately 28% for our fiscal year ending June 30, 2018, and 21% for subsequent fiscal years. However, the U.S. Tax Act eliminates the domestic manufacturing deduction and moves to a territorial system, which also eliminates the ability to credit certain foreign taxes that existed prior to enactment of the U.S. Tax Act. For the nine months ended March 31, 2018, these impacts resulted in a net tax benefit of approximately $210 million, as the majority of the impact of the lower blended U.S. federal rate was offset by the inability to fully credit foreign taxes that were previously included in our estimated annual effective tax rate. This impact, along with the transitional taxes discussed in the paragraph below, are being reflected in the Corporate Segment for both management and segment reporting for fiscal 2018. There are also certain transitional impacts of the U.S. Tax Act. As part of the transition to the new territorial tax system, the U.S. Tax Act imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. In addition, the reduction of the U.S. corporate tax rate will cause us to adjust our U.S. deferred tax assets and liabilities to the lower federal base rate of 21%. These transitional impacts resulted in a provisional net charge of $650 million for the nine months ended March 31, 2018, comprised of an estimated repatriation tax charge of $3.9 billion (comprised of the U.S. repatriation taxes and foreign withholding taxes) and an estimated net deferred tax benefit of $3.2 billion. The changes included in the U.S. Tax Act are broad and complex. The final transition impacts of the U.S. Tax Act may differ from the above estimate, possibly materially, due to, among other things, changes in interpretations of the U.S. Tax Act, any legislative action to address questions that arise because of the U.S. Tax Act, any changes in accounting standards for income taxes or related interpretations in response to the U.S. Tax Act, or any updates or changes to estimates the company has utilized to calculate the transition impacts, including impacts from changes to current year earnings estimates and foreign exchange rates of foreign subsidiaries. The Securities Exchange Commission has issued rules that would allow for a measurement period of up to one year after the enactment date of the U.S. Tax Act to finalize the recording of the related tax impacts. We currently anticipate finalizing and recording any resulting adjustments within the one year time period provided by the Securities Exchange Commission.
|
SEGMENT INFORMATION |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting Disclosure [Text Block] | Segment Information As discussed in Note 11, the Company completed the divestiture of the Beauty Brands business on October 1, 2016. The Beauty Brands business is presented as discontinued operations and is excluded from segment results for the nine months ended March 31, 2017. Following is a summary of reportable segment results:
|
GOODWILL AND OTHER INTANGIBLE ASSETS |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Text Block] | Goodwill and Other Intangible Assets Goodwill is allocated by reportable segment as follows:
Goodwill increased from June 30, 2017 due to currency translation and acquisitions. Identifiable intangible assets at March 31, 2018 are comprised of:
Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist of brands. The amortization expense of intangible assets for the three months ended March 31, 2018 and 2017 was $75 and $79, respectively. For the nine months ended March 31, 2018 and 2017, the amortization expense of intangible assets was $227 and $248, respectively. The test to evaluate goodwill for impairment is a two-step process. In the first step, we compare the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment. The business unit valuations used to test goodwill and intangible assets for impairment are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment, margin expansion and Company business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. Most of our goodwill reporting units are comprised of a combination of legacy and acquired businesses and as a result have fair value cushions that, at a minimum, exceed two times their underlying carrying values. Certain of our goodwill reporting units, in particular Shave Care and Appliances, are comprised entirely of acquired businesses and as a result, have fair value cushions that are not as high. Both of these wholly acquired reporting units have fair value cushions (the fair values currently exceed the underlying carrying values). However, the overall Shave Care cushion and the related Gillette indefinite-lived intangible asset cushion have both been reduced to below 10%, both due in large part to an increased competitive market environment in the U.S., a deceleration of category growth caused by changing grooming habits and significant currency devaluations in a number of countries relative to the U.S. dollar that have occurred in recent years and resulted in reduced cash flow projections. As a result, this reporting unit and indefinite-lived intangible asset are more susceptible to impairment risk. The most significant assumptions utilized in the determination of the estimated fair values of Shave Care reporting unit and the Gillette indefinite-lived intangible asset are the residual net sales and earnings growth rates and discount rate. The residual growth rate represents the expected rate at which the reporting unit and Gillette brand are expected to grow beyond the shorter term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the reporting unit and brand operating plans, and approximates expected long term category market growth rates. The residual growth rate is dependent on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. While management can and has implemented strategies to address these events, significant changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that could trigger future impairment charges of the business unit's goodwill and indefinite-lived intangibles. As of March 31, 2018, the carrying values of Shave Care goodwill and the Gillette indefinite-lived intangible asset are $19.9 billion and $15.7 billion, respectively. The table below provides a sensitivity analysis for the Shave Care reporting unit and the Gillette indefinite lived intangible asset, utilizing reasonably possible changes in the assumptions for the residual growth rate and the discount rate, to demonstrate the potential impacts to the estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 50 basis point decrease to our residual growth rate or a 50 basis point increase to our discount rate.
|
EARNINGS PER SHARE |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Text Block] | Earnings Per Share Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble, less preferred dividends (net of related tax benefits), by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated on the basis of the weighted average number of common shares outstanding plus the dilutive effect of stock options and other stock-based awards and the assumed conversion of preferred stock. Net earnings per share were as follows:
(3) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
|
SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Employee Benefit Plans [Text Block] | Share-Based Compensation and Postretirement Benefits The following table provides a summary of our share-based compensation expense and postretirement benefit costs:
|
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk Management Activities and Fair Value Measurements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk Management And Fair Value [Text Block] | Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the nine months ended March 31, 2018. The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were remeasured at fair value on a non-recurring basis for the nine months ended March 31, 2018. The following table sets forth the Company’s financial assets as of March 31, 2018 and June 30, 2017 that are measured at fair value on a recurring basis during the period:
Investment securities are presented in Available-for-sale investment securities and Other noncurrent assets. The amortized cost of U.S. government securities with maturities less than one year was $2,303 as of March 31, 2018 and $2,494 as of June 30, 2017. The amortized cost of U.S. government securities with maturities between one and five years was $3,961 as of March 31, 2018 and $3,824 as of June 30, 2017. The amortized cost of Corporate bond securities with maturities of less than a year was $1,216 as of March 31, 2018 and $730 as of June 30, 2017. The amortized cost of Corporate bond securities with maturities between one and five years was $2,894 as of March 31, 2018 and $2,547 as of June 30, 2017. The Company's investments measured at fair value are generally classified as Level 2 within the fair value hierarchy. There are no material investment balances classified as Level 1 or Level 3 within the fair value hierarchy, or using net asset value as a practical expedient. Fair values are generally estimated based upon quoted market prices for similar instruments. The fair value of long-term debt was $25,472 and $21,396 as of March 31, 2018 and June 30, 2017, respectively. This includes the current portion ($1,763 and $1,694 as of March 31, 2018 and June 30, 2017, respectively) of debt instruments. Certain long-term debt is recorded at fair value. Certain long-term debt is not recorded at fair value on a recurring basis but is measured at fair value for disclosure purposes. Long-term debt with fair value of $1,862 and $1,716 as of March 31, 2018 and June 30, 2017, respectively, is classified as Level 2 within the fair value hierarchy. All remaining long-term debt is classified as Level 1 within the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments. The following table sets forth the notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of March 31, 2018 and June 30, 2017:
All derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. All derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. The total notional amount of contracts outstanding at the end of the period is indicative of the Company's derivative activity during the period. All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and nine months ended March 31, 2018 and 2017 are as follows:
(3) The gain or loss on foreign currency contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings in SG&A. This gain or loss substantially offsets the foreign currency mark-to-market impact of the related exposure.
|
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statement of Comprehensive Income [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comprehensive Income (Loss) Note [Text Block] | Accumulated Other Comprehensive Income/(Loss) The table below presents the changes in Accumulated other comprehensive income/(loss) by component and the reclassifications out of Accumulated other comprehensive income/(loss):
The below provides additional details on the amounts reclassified from AOCI into the Consolidated Statement of Earnings:
• Pension and other retiree benefits: amounts reclassified from AOCI into Cost of products sold and SG&A and included in the computation of net periodic postretirement costs.
|
RESTRUCTURING PROGRAM |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities Disclosure [Text Block] | Restructuring Program The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before-tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. In fiscal 2017, the Company announced specific elements of a multi-year productivity and cost savings plan to further reduce costs in the areas of supply chain, certain marketing activities and overhead expenses. During fiscal years 2018 and 2019, the Company expects to incur approximately $1.2 billion in before-tax restructuring costs under the plan. This program is expected to result in meaningful incremental non-manufacturing enrollment reductions, along with further optimization of the supply chain and other manufacturing processes. Restructuring costs incurred consist primarily of costs to separate employees, asset-related costs to exit facilities and other costs. For the three and nine month periods ended March 31, 2018, the Company incurred total restructuring charges of approximately $205 and $516, respectively. For the three and nine month periods ended March 31, 2018, $75 and $162 of these charges were recorded in SG&A, respectively. For the three and nine month periods ended March 31, 2018, $130 and $354 of these charges were recorded in Cost of products sold, respectively. The following table presents restructuring activity for the nine months ended March 31, 2018:
Separation Costs Employee separation charges for the three and nine month periods ended March 31, 2018 relate to severance packages for approximately 430 and 1,410 employees, respectively. Separations related to non-manufacturing employees were approximately 190 and 580 for the three and nine month periods ended March 31, 2018, respectively. The packages were predominantly voluntary and the amounts were calculated based on salary levels and past service periods. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer. Asset-Related Costs Asset-related costs consist of both asset write-downs and accelerated depreciation. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These assets relate primarily to manufacturing consolidations and technology standardizations. The asset-related charges will not have a significant impact on future depreciation charges. Other Costs Other restructuring-type charges are incurred as a direct result of the restructuring program. Such charges primarily include asset removal and termination of contracts related to supply chain optimization. Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges are funded by and included within Corporate for both management and segment reporting. Accordingly, all of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:
(1) Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities.
|
COMMITMENTS AND CONTINGENCIES |
9 Months Ended |
---|---|
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies Disclosure [Text Block] | Commitments and Contingencies Litigation The Company is subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark, advertising, contracts, environmental, labor and employment and tax. With respect to these and other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in approximately 140 taxable jurisdictions and, at any point in time, has 50 – 60 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2008 and forward. We are generally not able to reliably estimate the ultimate settlement amounts until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions could increase or decrease within the next 12 months. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items. Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the year ended June 30, 2017.
|
DISCONTINUED OPERATIONS |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] | Discontinued Operations On October 1, 2016, the Company completed the divestiture of four product categories to Coty, Inc. (“Coty”). The divestiture included 41 of the Company's beauty brands (“Beauty Brands”), including the global salon professional hair care and color, retail hair color, cosmetics and a majority of the fine fragrance businesses, along with select hair styling brands. The form of the divestiture transaction was a Reverse Morris Trust split-off, in which P&G shareholders were given the election to exchange their P&G shares for shares of a new corporation that held the Beauty Brands (Galleria Co.), and then immediately exchange those shares for Coty shares. The value P&G received in the transaction was $11.4 billion. The value was comprised of 105 million shares of common stock of the Company, which were tendered by shareholders of the Company and exchanged for the Galleria Co. shares, valued at approximately $9.4 billion, and the assumption of $1.9 billion of debt by Galleria Co. The shares tendered in the transaction were reflected as an addition to treasury stock and the cash received related to the debt assumed by Coty was reflected as an investing activity in the Consolidated Statement of Cash Flows. The Company recorded an after-tax gain on the final transaction of $5.3 billion, net of transaction and related costs. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the Beauty Brands business are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for the nine months ended March 31, 2017. The Beauty Brands were historically part of the Company's Beauty reportable segment.The following is selected financial information underlying the Net earnings from discontinued operations for the Beauty Brands:
The Beauty Brands incurred transition costs of $167, after-tax, for the three months ended September 30, 2016, included in the above table. Residual transaction costs for the three months ended December 31, 2016 are included in the gain on the sale of business in the table above. The following is selected financial information related to cash flows from discontinued operations for the Beauty Brands:
|
SUBSEQUENT EVENT |
9 Months Ended |
---|---|
Mar. 31, 2018 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | Subsequent Event On April 18, 2018, the Company entered into an agreement to acquire the over the counter (OTC) healthcare business of Merck KGaA for €3.375 billion ($4.2 billion based on current exchange rates). This business primarily sells OTC consumer healthcare products, primarily in Europe, Latin America and Asia markets. We anticipate the transaction to close during fiscal year 2019, with the timing subject to regulatory clearance and customary closing conditions. On April 5, 2018, the Company reached an agreement to dissolve our PGT Healthcare partnership, a venture between the Company and Teva Pharmaceutical Industries, Ltd (Teva) in the OTC consumer healthcare business. This transaction is expected to close in July 2018 and will be accounted for as a sale of the Teva portion of the business.
|
SEGMENT INFORMATION (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] | Following is a summary of reportable segment results:
|
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill [Table Text Block] | Goodwill is allocated by reportable segment as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets and Goodwill [Table Text Block] | Identifiable intangible assets at March 31, 2018 are comprised of:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] | The table below provides, in isolation, the estimated fair value impacts related to a 50 basis point decrease to our residual growth rate or a 50 basis point increase to our discount rate.
|
EARNINGS PER SHARE (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | Net earnings per share were as follows:
(3) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
|
SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Employee Benefit Plans [Table Text Block] | The following table provides a summary of our share-based compensation expense and postretirement benefit costs:
(1) The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2017, excluding the settlement, curtailment, and special termination costs related to the divestiture of the Beauty Brands business reported in Net earnings from discontinued operations.
|
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk Management Activities and Fair Value Measurements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | The following table sets forth the Company’s financial assets as of March 31, 2018 and June 30, 2017 that are measured at fair value on a recurring basis during the period:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments [Table Text Block] | The following table sets forth the notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of March 31, 2018 and June 30, 2017:
(1) The fair value of the derivative asset/liability directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, net of the fair value adjustment, was $4,775 as of March 31, 2018 and $4,705 as of June 30, 2017, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments, Gain (Loss) [Table Text Block] | The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and nine months ended March 31, 2018 and 2017 are as follows:
(3) The gain or loss on foreign currency contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings in SG&A. This gain or loss substantially offsets the foreign currency mark-to-market impact of the related exposure.
|
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statement of Comprehensive Income [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | The table below presents the changes in Accumulated other comprehensive income/(loss) by component and the reclassifications out of Accumulated other comprehensive income/(loss):
|
RESTRUCTURING PROGRAM (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restructuring Reserve by Type of Cost [Table Text Block] | The following table presents restructuring activity for the nine months ended March 31, 2018:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Costs [Table Text Block] | However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:
(1) Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities.
|
DISCONTINUED OPERATIONS (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups - Beauty Brands [Table Text Block] | The following is selected financial information related to cash flows from discontinued operations for the Beauty Brands:
(1) The income tax benefit of the Beauty Brands divestiture represents the reversal of underlying deferred tax balances offset by current tax expense related to the transaction.
|
NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - U.S. TAX REFORM (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Jan. 01, 2018 |
|
Income Tax Expense (Benefit) | $ 713 | $ 780 | $ 3,066 | $ 2,338 | |||
U.S. Tax Cuts and Jobs Act, Effective 2018 | |||||||
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | 210 | ||||||
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent | 21.00% | ||||||
Income Tax Expense (Benefit) | 650 | ||||||
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount | 3,900 | ||||||
Deferred Federal Income Tax Expense (Benefit) | $ 3,200 | ||||||
U.S. Tax Cuts and Jobs Act, Effective 2018 | Scenario, Forecast | |||||||
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 21.00% | 28.00% |
SEGMENT INFORMATION (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
|
Segment Reporting Information [Line Items] | ||||
Net Sales | $ 16,281 | $ 15,605 | $ 50,329 | $ 48,979 |
Earnings/(Loss) from Continuing Operations Before Income Taxes | 3,253 | 3,336 | 11,037 | 10,330 |
Net Earnings/(Loss) from Continuing Operations | 2,540 | 2,556 | 7,971 | 7,992 |
Beauty | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 2,934 | 2,675 | 9,305 | 8,613 |
Earnings/(Loss) from Continuing Operations Before Income Taxes | 642 | 531 | 2,331 | 2,028 |
Net Earnings/(Loss) from Continuing Operations | 488 | 396 | 1,775 | 1,528 |
Grooming | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 1,550 | 1,525 | 4,903 | 4,972 |
Earnings/(Loss) from Continuing Operations Before Income Taxes | 422 | 437 | 1,367 | 1,580 |
Net Earnings/(Loss) from Continuing Operations | 334 | 333 | 1,086 | 1,217 |
Health Care | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 1,934 | 1,841 | 6,048 | 5,774 |
Earnings/(Loss) from Continuing Operations Before Income Taxes | 467 | 470 | 1,590 | 1,574 |
Net Earnings/(Loss) from Continuing Operations | 305 | 310 | 1,065 | 1,052 |
Fabric & Home Care | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 5,262 | 4,957 | 16,079 | 15,529 |
Earnings/(Loss) from Continuing Operations Before Income Taxes | 1,001 | 972 | 3,281 | 3,226 |
Net Earnings/(Loss) from Continuing Operations | 635 | 599 | 2,118 | 2,052 |
Baby, Feminine & Family Care | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 4,458 | 4,471 | 13,616 | 13,711 |
Earnings/(Loss) from Continuing Operations Before Income Taxes | 852 | 890 | 2,749 | 2,973 |
Net Earnings/(Loss) from Continuing Operations | 539 | 555 | 1,766 | 1,932 |
Corporate | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 143 | 136 | 378 | 380 |
Earnings/(Loss) from Continuing Operations Before Income Taxes | (131) | 36 | (281) | (1,051) |
Net Earnings/(Loss) from Continuing Operations | $ 239 | $ 363 | $ 161 | $ 211 |
GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details) $ in Millions |
9 Months Ended |
---|---|
Mar. 31, 2018
USD ($)
| |
Goodwill [Roll Forward] | |
Goodwill at June 30, 2017 | $ 44,699 |
Goodwill, Acquisitions and Divestitures | 82 |
Goodwill, Translation and Other | 1,394 |
Goodwill at March 31, 2018 | 46,175 |
Beauty | |
Goodwill [Roll Forward] | |
Goodwill at June 30, 2017 | 12,791 |
Goodwill, Acquisitions and Divestitures | 82 |
Goodwill, Translation and Other | 474 |
Goodwill at March 31, 2018 | 13,347 |
Grooming | |
Goodwill [Roll Forward] | |
Goodwill at June 30, 2017 | 19,627 |
Goodwill, Acquisitions and Divestitures | 0 |
Goodwill, Translation and Other | 587 |
Goodwill at March 31, 2018 | 20,214 |
Health Care | |
Goodwill [Roll Forward] | |
Goodwill at June 30, 2017 | 5,878 |
Goodwill, Acquisitions and Divestitures | 0 |
Goodwill, Translation and Other | 166 |
Goodwill at March 31, 2018 | 6,044 |
Fabric & Home Care | |
Goodwill [Roll Forward] | |
Goodwill at June 30, 2017 | 1,857 |
Goodwill, Acquisitions and Divestitures | 0 |
Goodwill, Translation and Other | 41 |
Goodwill at March 31, 2018 | 1,898 |
Baby, Feminine & Family Care | |
Goodwill [Roll Forward] | |
Goodwill at June 30, 2017 | 4,546 |
Goodwill, Acquisitions and Divestitures | 0 |
Goodwill, Translation and Other | 126 |
Goodwill at March 31, 2018 | $ 4,672 |
GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details) $ in Millions |
Mar. 31, 2018
USD ($)
|
---|---|
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | |
Gross Carrying Amount | $ 29,258 |
Accumulated Amortization | (5,129) |
Intangible Assets with Indefinite Lives | |
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | |
Gross Carrying Amount | 21,790 |
Accumulated Amortization | 0 |
Intangible Assets with Determinable Lives | |
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | |
Gross Carrying Amount | 7,468 |
Accumulated Amortization | $ (5,129) |
GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
Jun. 30, 2017 |
|
Other Significant Noncash Transactions [Line Items] | |||||
Amortization of Intangible Assets | $ 75 | $ 79 | $ 227 | $ 248 | |
Goodwill | $ 46,175 | $ 46,175 | $ 44,699 | ||
Shave Care | |||||
Other Significant Noncash Transactions [Line Items] | |||||
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount | 10.00% | 10.00% | |||
Goodwill | $ 19,900 | $ 19,900 | |||
Intangible Assets with Indefinite Lives | Gillette | |||||
Other Significant Noncash Transactions [Line Items] | |||||
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount | 10.00% | 10.00% | |||
Intangible Assets, Net (Including Goodwill) | $ 15,700 | $ 15,700 |
GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION OTHER (Details) |
Mar. 31, 2018 |
---|---|
Shave Care | |
Other Significant Noncash Transactions [Line Items] | |
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount | 10.00% |
GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details) |
Mar. 31, 2018 |
---|---|
50 bps Increase Discount Rate | Intangible Assets with Indefinite Lives | Gillette | |
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items] | |
Percent Change in Estimated Fair Value | (10.00%) |
50 bps Decrease Long-Term Growth | Intangible Assets with Indefinite Lives | Gillette | |
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items] | |
Percent Change in Estimated Fair Value | (7.00%) |
Goodwill | 50 bps Increase Discount Rate | Shave Care | |
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items] | |
Percent Change in Estimated Fair Value | (10.00%) |
Goodwill | 50 bps Decrease Long-Term Growth | Shave Care | |
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items] | |
Percent Change in Estimated Fair Value | (7.00%) |
EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | 9 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
||||||||||
Earnings Per Share Reconciliation [Abstract] | |||||||||||||
Net Earnings/(Loss) | $ 2,540 | $ 2,556 | $ 7,971 | $ 13,209 | |||||||||
Net Earnings Attributable to Noncontrolling Interest | (29) | (34) | (112) | (98) | |||||||||
Net Earnings/(Loss) Attributable to P&G (Diluted) | 2,511 | 2,522 | 7,859 | 13,111 | |||||||||
Preferred Dividends, Net of Tax Benefit | (74) | (60) | (198) | (184) | |||||||||
Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic) | $ 2,437 | $ 2,462 | $ 7,661 | $ 12,927 | |||||||||
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | |||||||||||||
Basic Weighted Average Common Shares Outstanding | 2,522.7 | 2,563.3 | 2,535.7 | 2,611.5 | |||||||||
Effect of Dilutive Securities | |||||||||||||
Conversion of Preferred Shares | [1] | 94.3 | 98.7 | 95.4 | 99.9 | ||||||||
Exercise of Stock Options and Other Unvested Equity Awards | [2] | 28.6 | 43.5 | 37.5 | 44.0 | ||||||||
Diluted Weighted Average Common Shares Outstanding | 2,645.6 | 2,705.5 | 2,668.6 | 2,755.4 | |||||||||
Basic Net Earnings/(Loss) Per Common Share | [3],[4] | $ 0.97 | $ 0.96 | $ 3.02 | $ 4.95 | ||||||||
Diluted Net Earnings/(Loss) Per Common Share | [3],[4] | $ 0.95 | $ 0.93 | $ 2.94 | $ 4.76 | ||||||||
Continuing Operations | |||||||||||||
Earnings Per Share Reconciliation [Abstract] | |||||||||||||
Net Earnings/(Loss) | $ 2,556 | $ 7,992 | |||||||||||
Net Earnings Attributable to Noncontrolling Interest | (34) | (98) | |||||||||||
Net Earnings/(Loss) Attributable to P&G (Diluted) | 2,522 | 7,894 | |||||||||||
Preferred Dividends, Net of Tax Benefit | (60) | (184) | |||||||||||
Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic) | $ 2,462 | $ 7,710 | |||||||||||
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | |||||||||||||
Basic Weighted Average Common Shares Outstanding | 2,563.3 | 2,611.5 | |||||||||||
Effect of Dilutive Securities | |||||||||||||
Conversion of Preferred Shares | [1] | 98.7 | 99.9 | ||||||||||
Exercise of Stock Options and Other Unvested Equity Awards | [2] | 43.5 | 44.0 | ||||||||||
Diluted Weighted Average Common Shares Outstanding | 2,705.5 | 2,755.4 | |||||||||||
Basic Net Earnings/(Loss) Per Common Share | [3] | $ 0.96 | $ 2.95 | ||||||||||
Diluted Net Earnings/(Loss) Per Common Share | [3] | $ 0.93 | $ 2.87 | ||||||||||
Discontinued Operations | |||||||||||||
Earnings Per Share Reconciliation [Abstract] | |||||||||||||
Net Earnings/(Loss) | $ 0 | $ 5,217 | |||||||||||
Net Earnings Attributable to Noncontrolling Interest | 0 | 0 | |||||||||||
Net Earnings/(Loss) Attributable to P&G (Diluted) | 0 | 5,217 | |||||||||||
Preferred Dividends, Net of Tax Benefit | 0 | 0 | |||||||||||
Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic) | $ 0 | $ 5,217 | |||||||||||
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | |||||||||||||
Basic Weighted Average Common Shares Outstanding | 2,563.3 | 2,611.5 | |||||||||||
Effect of Dilutive Securities | |||||||||||||
Conversion of Preferred Shares | [1] | 98.7 | 99.9 | ||||||||||
Exercise of Stock Options and Other Unvested Equity Awards | [2] | 43.5 | 44.0 | ||||||||||
Diluted Weighted Average Common Shares Outstanding | 2,705.5 | 2,755.4 | |||||||||||
Basic Net Earnings/(Loss) Per Common Share | [3] | $ 0 | $ 2.00 | ||||||||||
Diluted Net Earnings/(Loss) Per Common Share | [3] | $ 0 | $ 1.89 | ||||||||||
|
EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details) - shares shares in Millions |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
|||
Employee Stock Option | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | [1] | 54 | 7 | 24 | 16 | |
|
SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
||||
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract] | |||||||
Allocated Share-based Compensation Expense | $ 92 | $ 93 | $ 249 | $ 211 | |||
Pension Plan | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) | [1] | 53 | 77 | 156 | 430 | ||
Other Postretirement Benefit Plan | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) | [1] | $ (44) | $ (23) | $ (120) | $ 16 | ||
|
SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS - ADDITIONAL INFORMATION (Details) - Discontinued Operations |
9 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
| |
Pension Plan | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment | $ 186 |
Other Postretirement Benefit Plan | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment | $ 34 |
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) - USD ($) $ in Millions |
Mar. 31, 2018 |
Jun. 30, 2017 |
---|---|---|
Fair Value Asset | $ 10,332 | $ 9,700 |
U.S. Government Securities | ||
Fair Value Asset | 6,156 | 6,297 |
Corporate Bond Securities | ||
Fair Value Asset | 4,052 | 3,271 |
Other Investments | ||
Fair Value Asset | $ 124 | $ 132 |
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions |
Mar. 31, 2018 |
Jun. 30, 2017 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term Debt, Fair Value | $ 25,472 | $ 21,396 |
Long Term Debt, Current Maturities Measured at Fair Value | 1,763 | 1,694 |
Fair Value, Inputs, Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term Debt, Fair Value | 1,862 | 1,716 |
U.S. Government Securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis | 2,303 | 2,494 |
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis | 3,961 | 3,824 |
Corporate Bond Securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis | 1,216 | 730 |
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis | $ 2,894 | $ 2,547 |
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE (Details) - USD ($) $ in Millions |
Mar. 31, 2018 |
Jun. 30, 2017 |
|||
---|---|---|---|---|---|
Derivatives Not Designated as Hedging Instruments | Foreign Currency Contract | |||||
Derivative [Line Items] | |||||
Notional Amount | $ 5,793 | $ 4,969 | |||
Fair Value Asset/(Liability) | (35) | 18 | |||
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts | |||||
Derivative [Line Items] | |||||
Notional Amount | [1] | 4,705 | 4,552 | ||
Fair Value Asset/(Liability) | [1] | 91 | 178 | ||
Derivatives in Net Investment Hedging Relationships | Foreign Exchange Contract | |||||
Derivative [Line Items] | |||||
Notional Amount | 5,256 | 6,102 | |||
Fair Value Asset/(Liability) | $ (350) | $ (163) | |||
|
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE - ADDITIONAL INFORMATION (Details) (Details) - USD ($) $ in Millions |
Mar. 31, 2018 |
Jun. 30, 2017 |
||
---|---|---|---|---|
Underlying, Other | Derivatives in Fair Value Hedging Relationships | ||||
Derivative [Line Items] | ||||
Notional Amount | [1] | $ 4,775 | $ 4,705 | |
|
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (EFFECTIVE PORTION) (Details) - USD ($) $ in Millions |
Mar. 31, 2018 |
Jun. 30, 2017 |
---|---|---|
Foreign Exchange Contract | Derivatives in Net Investment Hedging Relationships | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Accumulated Other Comprehensive Income, Amount of Gain (Loss) Recognized on Derivatives | $ (239) | $ (104) |
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
||||||||
Derivatives Not Designated as Hedging Instruments | Foreign Currency Contract | |||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
Amount of Gain/(Loss) Recognized in Earnings | [1] | $ 123 | $ 155 | $ 121 | $ (29) | ||||||
Derivatives in Cash Flow Hedging Relationships | Foreign Currency Contract | |||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
Amount of Gain/(Loss) Reclassified from AOCI into Earnings | [2] | 0 | (25) | 0 | 74 | ||||||
Derivatives in Fair Value Hedging Relationships | |||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
Amount of Gain/(Loss) Recognized in Earnings | [3] | 0 | 0 | 0 | 0 | ||||||
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts | |||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
Amount of Gain/(Loss) Recognized in Earnings | [3] | (46) | (22) | (87) | (202) | ||||||
Derivatives in Fair Value Hedging Relationships | Debt | |||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
Amount of Gain/(Loss) Recognized in Earnings | [3] | $ 46 | $ 22 | $ 87 | $ 202 | ||||||
|
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
Jun. 30, 2017 |
||||||
Accumulated Other Comprehensive Income/(Loss) | $ (13,891) | $ (13,891) | $ (14,632) | |||||||
OCI before Reclassifications | 553 | |||||||||
Other Comprehensive Income (Loss), Net of Tax | 280 | $ 567 | 741 | $ (48) | ||||||
Hedges | ||||||||||
Accumulated Other Comprehensive Income/(Loss) | (4,135) | (4,135) | (2,947) | |||||||
OCI before Reclassifications | [1] | (1,188) | ||||||||
Other Comprehensive Income (Loss), Net of Tax | (1,188) | |||||||||
Investment Securities | ||||||||||
Accumulated Other Comprehensive Income/(Loss) | (160) | (160) | (25) | |||||||
OCI before Reclassifications | [1] | (129) | ||||||||
Other Comprehensive Income (Loss), Net of Tax | (135) | |||||||||
Amounts Reclassified from AOCI | ||||||||||
Other Comprehensive Income (Loss), Net of Tax | 188 | |||||||||
Amounts Reclassified from AOCI | Hedges | ||||||||||
Other Comprehensive Income (Loss), Net of Tax | [2] | 0 | ||||||||
Amounts Reclassified from AOCI | Investment Securities | ||||||||||
Other Comprehensive Income (Loss), Net of Tax | [2] | (6) | ||||||||
Pension and Other Retiree Benefits | ||||||||||
Accumulated Other Comprehensive Income/(Loss) | (4,286) | (4,286) | (4,397) | |||||||
OCI before Reclassifications | [1] | (83) | ||||||||
Other Comprehensive Income (Loss), Net of Tax | 111 | |||||||||
Pension and Other Retiree Benefits | Amounts Reclassified from AOCI | ||||||||||
Other Comprehensive Income (Loss), Net of Tax | [2] | 194 | ||||||||
Financial Statement Translation | ||||||||||
Accumulated Other Comprehensive Income/(Loss) | $ (5,310) | (5,310) | $ (7,263) | |||||||
OCI before Reclassifications | 1,953 | |||||||||
Other Comprehensive Income (Loss), Net of Tax | 1,953 | |||||||||
Financial Statement Translation | Amounts Reclassified from AOCI | ||||||||||
Other Comprehensive Income (Loss), Net of Tax | $ 0 | |||||||||
|
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - NET OF TAX EXPENSE (BENEFIT) (Details) $ in Millions |
9 Months Ended | |||||
---|---|---|---|---|---|---|
Mar. 31, 2018
USD ($)
| ||||||
Hedges | ||||||
Other Comprehensive Income (Loss) before Reclassifications, Tax | $ (578) | [1] | ||||
Investment Securities | ||||||
Other Comprehensive Income (Loss) before Reclassifications, Tax | 0 | [1] | ||||
Pension and Other Retiree Benefits | ||||||
Other Comprehensive Income (Loss) before Reclassifications, Tax | (12) | [1] | ||||
Amounts Reclassified from AOCI | Hedges | ||||||
Other Comprehensive Income (Loss), Tax | 0 | [2] | ||||
Amounts Reclassified from AOCI | Investment Securities | ||||||
Other Comprehensive Income (Loss), Tax | 0 | [2] | ||||
Amounts Reclassified from AOCI | Pension and Other Retiree Benefits | ||||||
Other Comprehensive Income (Loss), Tax | $ 69 | [2] | ||||
|
RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details) $ in Millions |
3 Months Ended | 6 Months Ended | 9 Months Ended | |
---|---|---|---|---|
Mar. 31, 2018
USD ($)
employee
|
Dec. 31, 2017
USD ($)
|
Mar. 31, 2018
USD ($)
employee
|
Jun. 30, 2019
USD ($)
|
|
Restructuring Charges | $ 205 | $ 311 | $ 516 | |
Minimum | ||||
Restructuring and Related Cost, Amounts Historically Incurred | 250 | |||
Maximum | ||||
Restructuring and Related Cost, Amounts Historically Incurred | 500 | |||
Selling, General and Administrative Expense | ||||
Restructuring Charges | 75 | 162 | ||
Cost of Products Sold | ||||
Restructuring Charges | 130 | $ 354 | ||
Separations | ||||
Restructuring Charges | $ 69 | $ 113 | ||
Restructuring and Related Cost, Number of Severance Packages Executed | employee | 430 | 1,410 | ||
Non-Manufacturing Overhead Personnel | ||||
Restructuring and Related Cost, Number of Severance Packages Executed | employee | 190 | 580 | ||
Scenario, Forecast | ||||
Restructuring and Related Cost, Expected Cost | $ 1,200 |
RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | 9 Months Ended |
---|---|---|---|
Mar. 31, 2018 |
Dec. 31, 2017 |
Mar. 31, 2018 |
|
Restructuring Reserve [Roll Forward] | |||
Accrual Balance June 30, 2017 | $ 277 | $ 277 | |
Restructuring Charges | $ 205 | 311 | 516 |
Cash Spent | (290) | ||
Charges Against Assets | (232) | ||
Accrual Balance March 31, 2018 | 271 | 271 | |
Separations | |||
Restructuring Reserve [Roll Forward] | |||
Accrual Balance June 30, 2017 | 228 | 228 | |
Restructuring Charges | 69 | 113 | |
Cash Spent | (177) | ||
Charges Against Assets | 0 | ||
Accrual Balance March 31, 2018 | 233 | 233 | |
Asset-related Costs | |||
Restructuring Reserve [Roll Forward] | |||
Accrual Balance June 30, 2017 | 0 | 0 | |
Restructuring Charges | 88 | 144 | |
Cash Spent | 0 | ||
Charges Against Assets | (232) | ||
Accrual Balance March 31, 2018 | 0 | 0 | |
Other Costs | |||
Restructuring Reserve [Roll Forward] | |||
Accrual Balance June 30, 2017 | 49 | 49 | |
Restructuring Charges | 48 | $ 54 | |
Cash Spent | (113) | ||
Charges Against Assets | 0 | ||
Accrual Balance March 31, 2018 | $ 38 | $ 38 |
RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | 9 Months Ended | ||
---|---|---|---|---|---|
Mar. 31, 2018 |
Dec. 31, 2017 |
Mar. 31, 2018 |
|||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | $ 205 | $ 311 | $ 516 | ||
Beauty | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | 11 | 44 | |||
Grooming | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | 10 | 21 | |||
Health Care | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | 7 | 14 | |||
Fabric & Home Care | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | 26 | 81 | |||
Baby, Feminine & Family Care | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | 65 | 166 | |||
Corporate | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Charges | [1] | $ 86 | $ 190 | ||
|
COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details) |
9 Months Ended |
---|---|
Mar. 31, 2018
audit
taxable_jurisdiction
| |
Loss Contingencies [Line Items] | |
Number of Taxable Jurisdictions | taxable_jurisdiction | 140 |
Minimum | |
Loss Contingencies [Line Items] | |
Number of Audits Typically Underway | 50 |
Maximum | |
Loss Contingencies [Line Items] | |
Number of Audits Typically Underway | 60 |
DISCONTINUED OPERATIONS - ADDITIONAL INFORMATION (Details) shares in Millions, $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Mar. 31, 2018
USD ($)
|
Mar. 31, 2017
USD ($)
|
Mar. 31, 2018
USD ($)
|
Mar. 31, 2017
USD ($)
|
Oct. 01, 2016
USD ($)
shares
|
|
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 0 | $ 0 | $ 0 | $ 5,217 | |
Beauty Brands | |||||
Disposal Groups - Number of Product Categories | 4 | ||||
Disposal Groups - Number of Brands | 41 | ||||
Disposal Group, Including Discontinued Operation, Consideration | $ 11,400 | ||||
Disposal Groups - Consideration Received (Shares) | shares | 105 | ||||
Disposal Groups - Equity of New Company | $ 9,400 | ||||
Disposal Groups - Value of Debt Assumed | $ 1,900 | ||||
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 5,300 | $ 5,217 |
DISCONTINUED OPERATIONS - ADDITIONAL INFORMATION ON TABLES (Details) $ in Millions |
3 Months Ended |
---|---|
Sep. 30, 2016
USD ($)
| |
Beauty Brands | |
Disposal Groups - Transition Cost | $ 167 |
DISCONTINUED OPERATIONS - NET EARNINGS FROM DISCONTINUED OPERATIONS FOR BEAUTY BRANDS (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
|||
Net Earnings/(Loss) from Discontinued Operations | $ 0 | $ 0 | $ 0 | $ 5,217 | ||
Beauty Brands | ||||||
Net Sales, Discontinued Operations | 1,159 | |||||
Cost of Products Sold, Discontinued Operations | 450 | |||||
Selling, General and Administrative Expense, Discontinued Operations | 783 | |||||
Interest Expense, Discontinued Operations | 14 | |||||
Disposal Group, Including Discontinued Operation, Other Income | 16 | |||||
Earnings/(Loss) from Discontinued Operations before Income Taxes | (72) | |||||
Income Taxes on Discontinued Operations | 46 | |||||
Gain on Disposition of Business, Before Income Taxes | 5,197 | |||||
Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal | [1] | (138) | ||||
Net Earnings/(Loss) from Discontinued Operations | $ 5,300 | $ 5,217 | ||||
|
DISCONTINUED OPERATIONS - CASH FLOWS FOR BEAUTY BRANDS (Details) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
|
Deferred Income Taxes | $ (1,826) | $ (382) |
Beauty Brands | ||
Depreciation and Amortization, Discontinued Operations | 24 | |
Deferred Income Taxes | (649) | |
Gain (Loss) on Disposition of Business | 5,210 | |
Increase (Decrease) in Accrued Taxes Payable | 307 | |
Income Taxes Paid | 204 | |
Capital Expenditure, Discontinued Operations | $ 38 |
SUBSEQUENT EVENT - ADDITIONAL INFORMATION (Details) - 3 months ended Jun. 30, 2018 € in Millions, $ in Billions |
USD ($) |
EUR (€) |
---|---|---|
Subsequent Event | ||
Subsequent Event [Line Items] | ||
Payments to Acquire Businesses, Gross | $ 4.2 | € 3,375 |
6TJ6XC_#%:2'ATQ\C!JEC2NI
M1^M0+2H^%<6?YUWHN$_S39XMM'U"MA"RE7 7X[ Y4,S\/7>\*@Q.Q,R]'WAX
MXO28^=[4P1E;$>]\\M9[KU6:ORO8-0@MF-.,R;:8%<&\^AHBVPMQROZA'Y)]
M_F$WQ4/D'[;A;_\CD.\*Y%$@_TL@?57C'B9[%81MFJK ='&<+*EQU'&4-]YU
M8N_C*[(_\'G ]02P,$% @ I(&33-#,N1.X 0
MTP, !D !X;"]W;W)K/+\?E0MS>"Y>*WX=P@ZO];9%AS__A']UTY\(^8QK>RZR/XY[NO#_3R>S_;V*7W)
MZB_%Y3<["-+SV:#^#_MJLP9O6]+4L2NRJON<[5ZJNLB'*$U3\O1[_WT\==^7
M_A\CAV*X T%Z%J@J?NM G(H('\64&\64$,!-;4&/130K(:@U]YUYB:MT^6B
M+"ZSLG\>SFG[V(D[W0S7KKW9C4[W7].?57/W=4DJ7 2O;:"!6?4,C9GD%MFX
MB+@20=. :RL(M6)%3G')&K$&B&"->#_*]LTH-PV5L+MD5U[>=)
XB,^O
M4 "$$2,NSZ(G9SDS5,!PB6&\&(RH99>\)%2U ?[I$0#B)5
MYT%4N1!_EV%1P9'+:2SFM.^Q_8*35O\^T/ /R_X!4$L#!!0 ( *2!DTQ5
MNN KGP( &@) 9 >&PO=V]R:W-H965TK?Z.Y":$EA/]+B"PAF@F;^*^$V!+B
M%0%-I9C>'+'$><;9Z/'IWQVPOD2;7:RZ7^JD:;8Y4^T1*GO-HRC)T%4+6
*N=LM3#OA]Z69SD[GRJ;4_E?,J/,DUR]E0ZXIAE?%K$>_;"Y*_BJ50SKV79)AG+1<)SIV2[F?N )FNL
M'33B=\+.HC-VJE1>.7^K)M^W,]>O(F(IV\B*(E:?$UNR-*V85!Q_&U*WW;-R
M[(X_V-YG:H-LZ-V?$*A.]KL,X7**K!6ISMDT.Z>7@+@,9]&X) BVQ):-R
M$LUA@!#DJ J,^1AC! ! )$8X X&HAL3ZD9BQ[>/Y4,T8:%+-T/9O9V%/XW?MV/*$C#_Q%<:P
M:?'8M72T'8"S8S)8!O7NEH++D[N%E9>*2ZGM=ZL7[6[Z#;%WTR"^M2\ *$X6
M.RA_@ZDIH"!2;&9B<":Y/3/0?[+-(^4[DZ>L5-Y>:'.]NEOP*(3F9B>"1W.2
M9_,NZ@8Y/VK;34Q?-H^#9J!%U3Y\4/?Z6O\#4$L#!!0 ( *2!DTQG\'M"
MPP( -X* 9 >&PO=V]R:W-H965T P?4$L#!!0 ( *2!DTR'3-,?NP$ -4# 9 >&PO=V]R:W-H
M965T9_PA&8A3LE=H]&,NV_27/01O+(8J5P^A'&0?AQBORGLN6"/!;DGP5?
MXDG$DQE_[ZT'7=[H$S6T+I6<$A6.:J3N1F1K8EO9N*3OG%^S7K7-'NLBOROQ
MT1%%S&/ Y!>8^TO,9@%#TAF#K8992+XH)/<$Q05!MDQ %@F()R 7!/DR0;%(
M4"PH(%>M")@L^!0!M,JO>A%!Y Q$R.W-E19\=D3NP?RB:C\(G>RDL8?MSZ23
MTH!E3%?V%O;VC